Other extrapyramidal and movement disorders in other diseases

G6_XTRAPYROTH

Stiff-Person syndrome: Stiff-man syndrome (SMS) is a rare neurological disorder comprising fluctuating trunk and limb stiffness, painful muscle spasms, task-specific phobia, an exaggerated startle response, and ankylosing deformities such as fixed lumbar hyperlordosis.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G25, G26* Hospital discharge: ICD-9 — 333 Hospital discharge: excluded ICD-9 — 3330\|3336 Cause of death: ICD-10 — G25, G26* Cause of death: ICD-9 — 333 Cause of death: excluded ICD-9 — 3330\|3336 2 out of 7 registries used, show all original rules.	6903
4. Check minimum number of events None	6903
5. Include endpoints G6_RLS	9471
6. Filter based on genotype QC (FinnGen only)	9471

Control definitions (FinnGen only)

Control exclude: G6_XTRAPYR

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF10

NAME	G6_XTRAPYROTH
CONTROL_EXCLUDE	G6_XTRAPYR
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_RLS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G25\|G26
HD_ICD_9	333
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL	3330\|3336
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G25\|G26
COD_ICD_9	333
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL	3330\|3336
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other extrapyramidal and movement disorders in other diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	57572	32364	24873
Only index persons	52038	29908	22130
Unadjusted period prevalence (%)
Whole population	0.82	0.93	0.69
Only index persons	0.99	1.10	0.84
Median age at first event (years)
Whole population	66.04	66.60	65.27
Only index persons	65.34	65.93	64.55

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9471	5579	3892
Unadjusted period prevalence (%)	1.83	1.90	1.72
Median age at first event (years)	63.69	61.86	66.32

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8182: Matched controls
81818

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N03AE01

ATC

clonazepam; systemic

8.4

323.0

1332

1856

C07AA05

ATC

propranolol; systemic

4.9

323.0

3028

8716

N05AH04

ATC

quetiapine; oral

3.4

323.0

1875

6601

G20

ICD-10 Finland

Parkinson disease

295.5

323.0

919

G25.0

ICD-10 Finland

Essential tremor

160.5

323.0

2647

243

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

+∞

323.0

766

G25.2

ICD-10 Finland

Other specified forms of tremor

128.3

323.0

449

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

64.3

323.0

1214

221

R25.1

ICD-10 Finland

Tremor, unspecified

21.8

323.0

1115

588

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

323.0

4001

N04BC04

ATC

ropinirole; oral

81.6

323.0

403

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

658.1

323.0

1139

N04BC05

ATC

pramipexole; oral

21.8

323.0

3199

2341

N03AX12

ATC

gabapentin; oral

3.6

323.0

2105

7178

N06AX11

ATC

mirtazapine; oral

2.5

297.4

3250

16971

N04BD01

ATC

selegiline; oral

69.6

295.3

341

N87

ICPC

Parkinsonism

59.5

294.2

348

N03AX16

ATC

pregabalin; oral

2.5

249.4

2530

12410

N05BA04

ATC

oxazepam; oral

2.3

214.3

2477

12791

G25.3

ICD-10 Finland

Myoclonus

419.9

206.2

206

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

1926.7

204.9

198

N06AB04

ATC

citalopram; systemic

2.4

199.9

2154

10673

G25.1

ICD-10 Finland

Drug-induced tremor

209.1

197.2

204

N06AX16

ATC

venlafaxine; oral

2.8

180.6

1377

5592

G47.3

ICD-10 Finland

Sleep apnoea

2.3

176.1

2005

10106

N06AX21

ATC

duloxetine; oral

2.9

174.5

1177

4416

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.3

167.4

960

3210

M79.6

ICD-10 Finland

Pain in limb

2.0

163.2

3172

19947

N03AA03

ATC

primidone; oral

109.8

157.7

172

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.8

156.2

1162

4615

R53

ICD-10 Finland

Malaise and fatigue

2.2

155.5

1955

10226

F51.0

ICD-10 Finland

Nonorganic insomnia

2.6

153.2

1264

5331

N05CF01

ATC

zopiclone; oral

1.9

145.8

2936

18491

N04BC09

ATC

rotigotine; transdermal

123.1

145.6

157

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

144.0

920

3300

N03AG01

ATC

valproic acid; systemic, rectal

3.6

142.4

693

2032

M54.5

ICD-10 Finland

Low back pain

1.9

140.4

2799

17500

AA1AD

NOMESCO Finland

CT of head and brain

2.0

139.2

2222

12759

G24.3

ICD-10 Finland

Spasmodic torticollis

28.8

135.5

186

N04BD02

ATC

rasagiline; oral

271.1

130.5

133

N05AH03

ATC

olanzapine; systemic

3.6

129.7

631

1845

N04AA02

ATC

biperiden; systemic

7.7

129.0

311

415

N06AB10

ATC

escitalopram; oral

2.1

128.9

1683

8844

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

73.9

126.9

145

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.1

125.0

766

2659

N05BA01

ATC

diazepam; systemic, rectal

2.3

123.1

1294

6140

N04

ICPC

Restless legs

21.0

122.9

185

N02BE01

ATC

paracetamol; systemic, rectal

2.1

121.5

7035

61286

R42

ICD-10 Finland

Dizziness and giddiness

2.0

121.2

2016

11648

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

115.5

680

2291

193

Kela drug reimbursment

Rasagiline

+∞

113.8

109

N02AX02

ATC

tramadol; systemic, rectal

1.7

112.4

3512

24907

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

106.5

2526

16382

A02BC02

ATC

pantoprazole; systemic

1.7

106.1

5280

42476

L03

ICPC

Low back symptom/complaint

1.9

104.8

2047

12431

R06.0

ICD-10 Finland

Dyspnoea

1.8

104.4

2171

13464

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

101.0

1210

6051

N06AB03

ATC

fluoxetine; oral

2.2

101.0

1149

5614

N03AX09

ATC

lamotrigine; oral

3.7

100.1

477

1364

N06AB06

ATC

sertraline; oral

2.4

98.6

949

4275

N05CF02

ATC

zolpidem; oral

2.0

97.6

1516

8435

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

96.9

2301

14830

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.5

96.5

864

3746

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

96.4

2827

19414

G24.9

ICD-10 Finland

Dystonia, unspecified

165.2

93.3

A02BC05

ATC

esomeprazole; systemic

1.6

92.7

3288

23738

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

92.1

973

4578

L17

ICPC

Foot/toe symptom/complaint

1.8

92.0

2128

13556

M03BX02

ATC

tizanidine; oral

1.6

91.5

4740

37734

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

+∞

90.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

90.3

2089

13296

N05AA02

ATC

levomepromazine; systemic

3.5

88.2

436

1283

N05AN01

ATC

lithium; oral

4.9

88.2

302

632

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

88.1

732

3039

N06AA09

ATC

amitriptyline; systemic

2.2

88.0

964

4606

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

437.2

87.3

R03AC02

ATC

salbutamol; inhalant

1.6

86.4

4086

31574

N05CD07

ATC

temazepam; oral

2.1

86.4

1146

5954

L28

ICPC

Limited function/disability (L)

1.9

85.4

1388

7811

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

85.0

3599

27005

N06AX12

ATC

bupropion; oral

3.1

84.0

509

1739

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

83.6

654

2622

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

83.5

569

2099

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

83.1

439

1359

N05BA12

ATC

alprazolam; oral

2.2

83.0

928

4469

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.7

82.3

293

639

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.8

81.6

243

433

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

81.6

2371

16054

M25.5

ICD-10 Finland

Pain in joint

1.7

79.1

2218

14838

R51.80

ICD-10 Finland

Headache

2.0

78.9

1168

6323

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

270.1

78.6

N05AX12

ATC

aripiprazole; systemic

3.9

78.5

339

890

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.5

78.1

391

1161

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

78.0

661

2769

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.4

77.9

698

3011

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

77.2

473

1627

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

76.7

1326

7601

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

75.8

3495

26514

N06AX26

ATC

vortioxetine; oral

3.0

75.7

480

1689

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

75.7

2867

20726

G44.2

ICD-10 Finland

Tension-type headache

2.0

75.5

1079

5754

G04BD12

ATC

mirabegron; oral

2.1

74.6

942

4774

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

74.0

1470

8822

M48.0

ICD-10 Finland

Spinal stenosis

2.0

73.9

1094

5910

SPAT1240

SPAT

Therapeutic discussion

2.2

73.8

807

3836

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

73.4

5211

43549

N03AX11

ATC

topiramate; oral

4.4

73.1

279

653

P06

ICPC

Sleep disturbance

2.2

72.6

811

3893

A04

ICPC

Weakness/tiredness general

2.0

71.4

1095

5992

G24.8

ICD-10 Finland

Other dystonia

186.6

71.2

L01

ICPC

Neck symptom/complaint

1.9

70.9

1123

6215

A02BC03

ATC

lansoprazole; oral

1.6

70.0

2351

16402

P01

ICPC

Feeling anxious/nervous/tense

2.3

69.7

701

3200

N05AX08

ATC

risperidone; systemic

2.4

69.6

654

2886

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

69.4

1726

11081

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

67.2

69.4

N06AX03

ATC

mianserin; oral

2.8

68.6

483

1815

J01DB01

ATC

cefalexin; oral

1.6

68.4

6359

56092

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

145.2

68.0

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

66.6

833

4192

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

66.6

911

4758

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.1

66.4

219

440

A02BC01

ATC

omeprazole; systemic

1.6

66.1

2218

15420

P76

ICPC

Depressive disorder

2.7

66.0

494

1926

A28

ICPC

Limited function/disability NOS

1.8

65.5

1264

7480

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.9

64.9

1123

6402

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

64.7

1389

8505

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

64.2

1715

11200

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

64.0

2119

14657

M79.1

ICD-10 Finland

Myalgia

1.9

63.7

1033

5752

WX110

NOMESCO Finland

Local anesthesy

1.5

62.7

5112

43204

S18

ICPC

Laceration/cut

1.5

62.6

3275

25192

R06.5

ICD-10 Finland

Mouth breathing

2.2

61.7

700

3371

N04BX02

ATC

entacapone; oral

+∞

61.5

TAB00

NOMESCO Finland

Lumbar puncture

2.9

60.8

396

1416

K02.1

ICD-10 Finland

Caries of dentine

1.5

60.7

4038

32599

3338X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Fragments of torsion dystonia

+∞

60.5

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

5.8

59.8

176

310

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

59.3

1818

12288

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

58.4

1016

5785

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

+∞

58.4

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.6

57.8

454

1815

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.0

57.5

192

392

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

57.4

3806

30561

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

57.2

2981

22770

C07AB07

ATC

bisoprolol; oral

1.5

56.9

3690

29482

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.1

56.8

338

1137

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

56.7

2408

17578

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

56.6

1244

7640

R52.9

ICD-10 Finland

Pain, unspecified

2.1

56.5

706

3541

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

56.4

1215

7416

SPAT1263

SPAT

Sampling

1.5

56.3

3249

25331

M01AE02

ATC

naproxen; oral, rectal

1.4

56.3

4160

34080

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

55.9

2890

22013

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

55.3

453

1855

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

55.1

4571

38236

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

4.0

55.0

229

582

P03

ICPC

Feeling depressed

2.2

55.0

627

3020

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

54.4

3975

32398

SPAT1301

SPAT

No procedures

1.5

54.3

2502

18558

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.9

54.1

349

1237

M79.7

ICD-10 Finland

Fibromyalgia

3.1

53.9

318

1064

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

53.7

1091

6528

P20

ICPC

Memory disturbance

1.8

53.7

1020

5976

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

53.0

1236

7714

SPAT1216

SPAT

Assessment of functional ability

1.7

52.9

1269

7983

N05AF03

ATC

chlorprothixene; systemic

3.6

52.4

249

709

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

52.3

1212

7545

A06AD11

ATC

lactulose; oral

1.7

52.3

1134

6922

R01AD09

ATC

mometasone; nasal

1.4

51.9

3228

25409

SPAT1254

SPAT

Administration of medicine

1.7

51.6

1157

7131

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

51.4

2237

16343

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.3

51.4

162

310

M01AB05

ATC

diclofenac; systemic, rectal

1.4

51.2

4965

42486

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

51.1

1496

9937

M01AH05

ATC

etoricoxib; oral

1.4

51.0

4279

35618

H03AA01

ATC

levothyroxine sodium; systemic

1.6

50.8

1807

12598

J01AA02

ATC

doxycycline; systemic

1.5

50.5

5996

53284

N08

ICPC

Abnormal involuntary movements

23.0

50.5

H02AB06

ATC

prednisolone; systemic

1.4

50.4

3526

28340

SPAT1053

SPAT

Memory test

1.7

50.2

1246

7906

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

50.1

3417

27317

N06AB05

ATC

paroxetine; oral

2.3

50.1

504

2292

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

49.9

352

1321

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

49.8

707

3728

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

49.3

624

3142

SPAT1260

SPAT

Consultation of another employee

1.6

48.8

1413

9341

A01

ICPC

Pain general/multiple sites

2.0

48.8

637

3245

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

48.5

532

2515

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

48.5

3138

24788

R02

ICPC

Shortness of breath/dyspnoea

1.8

48.4

970

5766

XA800

NOMESCO Finland

Neuropsychological investigation

2.7

48.3

340

1275

SPAT1229

SPAT

Assessment of need for aid

2.0

48.3

675

3535

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

48.1

2857

22184

G23.1

ICD-10 Finland

Progressive supranuclear ophthalmoplegia [Steele-Richardson-Olszewski]

+∞

47.9

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

47.7

517

2431

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

47.6

327

1208

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

47.5

918

5390

F32.1

ICD-10 Finland

Moderate depressive episode

2.5

47.5

390

1598

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

23.6

47.4

P29

ICPC

Psychological sympt/compl other

2.5

47.2

395

1635

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.9

47.0

159

330

R35

ICD-10 Finland

Polyuria

2.2

46.6

523

2497

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.6

46.2

218

618

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

46.1

278

945

N06AX22

ATC

agomelatine; oral

4.0

46.0

190

480

R03DC03

ATC

montelukast; oral

1.7

45.9

1174

7492

F34.1

ICD-10 Finland

Dysthymia

2.9

45.6

295

1047

N06AX05

ATC

trazodone; oral

3.3

45.5

237

726

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

45.3

1713

12061

R05

ICD-10 Finland

Cough

1.6

45.1

1469

9985

J01CA04

ATC

amoxicillin; systemic

1.4

45.0

6049

54250

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.2

45.0

506

2420

N17

ICPC

Vertigo/dizziness

1.8

45.0

884

5215

J02AC01

ATC

fluconazole; systemic

1.4

45.0

2818

22028

R13

ICD-10 Finland

Dysphagia

2.1

44.9

528

2572

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

44.7

3985

33187

F32

ICD-10 Finland

Depressive episode

2.4

44.5

387

1636

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

44.4

1314

8710

N30.0

ICD-10 Finland

Acute cystitis

1.7

44.2

1055

6601

N06AA12

ATC

doxepin; systemic

2.2

44.1

465

2156

XKD00

NOMESCO Finland

Uroflowmetry

1.6

44.0

1189

7696

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

44.0

1747

12428

R60.0

ICD-10 Finland

Localized oedema

1.8

43.9

869

5135

L02

ICPC

Back symptom/complaint

1.9

43.9

655

3513

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

43.8

208

593

M54

ICD-10 Finland

Dorsalgia

1.8

43.6

815

4726

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.3

43.5

119

192

N06AA06

ATC

trimipramine; systemic

3.1

43.3

247

806

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

42.9

798

4619

P99

ICPC

Psychological disorders other

3.3

42.9

225

693

R25.2

ICD-10 Finland

Cramp and spasm

3.3

42.4

220

672

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

14.5

42.4

SPAT1307

SPAT

Psychosocial counselling and guidance

2.4

42.3

387

1677

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

42.0

1486

10280

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

41.9

876

5263

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

50.3

41.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

41.5

2942

23429

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

41.3

1091

7008

N06AG02

ATC

moclobemide; oral

2.4

41.2

379

1645

3331A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Essential and other specified forms of tremor

+∞

40.6

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

40.5

737

4234

Z01.2

ICD-10 Finland

Dental examination

1.4

40.5

2825

22401

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

40.4

785

4604

N05AB03

ATC

perphenazine; systemic, rectal

2.7

40.4

295

1132

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

40.4

1434

9918

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.6

40.0

311

1237

A02BA02

ATC

ranitidine; systemic

1.5

39.9

1499

10502

R06AE07

ATC

cetirizine; oral

1.4

39.8

3077

24825

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

39.6

543

2815

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.5

39.6

1951

14474

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

39.4

368

1610

N05BE01

ATC

buspirone; oral

3.0

39.4

242

834

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

39.3

372

1639

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.4

39.1

195

579

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.8

39.0

171

457

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

38.9

730

4230

L08

ICPC

Shoulder symptom/complaint

1.5

38.5

1387

9610

M01AC06

ATC

meloxicam; systemic, rectal

1.4

38.4

2666

21066

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

38.3

828

5015

J45

ICD-10 Finland

Asthma

1.8

38.2

722

4196

WX290

NOMESCO Finland

Other blockade of nerve

1.4

37.7

2835

22698

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

28.5

37.7

SPAT1234

SPAT

Support of social functional capacity

2.2

37.6

413

1952

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

37.6

3044

24674

N29

ICPC

Neurological sympt/complt other

3.4

37.6

186

549

R52.2

ICD-10 Finland

Other chronic pain

2.6

37.5

285

1118

UKC02

NOMESCO Finland

Cystoscopy

1.6

37.4

1224

8287

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

37.4

916

5751

UJF32

NOMESCO Finland

Coloscopy

1.4

37.3

1921

14348

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

36.9

2740

21868

L15

ICPC

Knee symptom/complaint

1.5

36.8

1514

10792

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

36.7

748

4448

D82

ICPC

Teeth/gum disease

1.4

36.6

2274

17580

E0000UV

ATC

1.4

36.5

2808

22538

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

36.4

944

6022

N03AF01

ATC

carbamazepine; oral, rectal

2.1

36.2

410

1963

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

36.2

140

334

S06.0

ICD-10 Finland

Concussion

1.8

36.0

728

4322

F31

ICD-10 Finland

Bipolar affective disorder

4.9

35.9

120

247

KMAK

NOMESCO Finland

1.3

35.8

3554

29690

G25.5

ICD-10 Finland

Other chorea

+∞

35.4

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

35.3

892

5644

A98

ICPC

Health maint/preventive medicine

1.7

35.3

7555

71896

C03CA01

ATC

furosemide; systemic

1.4

35.1

2128

16355

R01AD08

ATC

fluticasone; nasal

1.4

35.0

1948

14734

G04CA02

ATC

tamsulosin; oral

1.5

35.0

1543

11150

SPAT1153

SPAT

Removal of sutures

1.4

34.9

2411

18958

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.7

34.9

246

924

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

34.8

1467

10499

R55

ICD-10 Finland

Syncope and collapse

1.7

34.7

810

5012

R07.3

ICD-10 Finland

Other chest pain

1.8

34.7

687

4048

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.0

34.6

142

359

L12

ICPC

Hand/finger symptom/complaint

1.6

34.6

1002

6573

R05

ICPC

Cough

1.5

34.5

1578

11484

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

34.5

718

4296

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

34.5

413

2025

3339X

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Other and unspecified extrapyramidal diseases and abnormal movement disorders

+∞

34.4

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

34.2

1016

6709

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

34.1

325

1438

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

34.1

172

516

P01AB01

ATC

metronidazole; oral, rectal

1.4

34.1

2796

22604

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

34.1

471

2450

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

34.0

2586

20647

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.4

33.9

169

502

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

33.8

415

2056

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

33.8

235

876

Z71.8

ICD-10 Finland

Other specified counselling

1.5

33.7

1613

11839

WZA90

NOMESCO Finland

Other doctors statement

1.5

33.6

1573

11494

SPAT1243

SPAT

Psychiatric/psychological examination

3.1

33.4

189

617

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.3

33.3

172

525

K59.1

ICD-10 Finland

Functional diarrhoea

2.1

33.3

396

1937

SPAT1310

SPAT

Counselling related to known health issue

1.4

33.0

2335

18393

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.4

33.0

167

503

U02

ICPC

Urinary frequency/urgency

1.6

32.9

958

6285

SPAT1312

SPAT

General health counselling

1.4

32.9

2297

18053

R03BA02

ATC

budesonide; inhalant

1.5

32.6

1230

8579

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.2

32.5

333

1525

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

32.5

1767

13282

H81

ICPC

Excessive ear wax

1.5

32.4

1191

8262

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

32.4

1691

12612

K30

ICD-10 Finland

Functional dyspepsia

1.7

32.3

755

4669

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

32.2

1236

8651

R00.2

ICD-10 Finland

Palpitations

1.9

32.2

511

2795

N06DA03

ATC

rivastigmine; oral, transdermal

2.4

32.0

276

1161

M03BX01

ATC

baclofen; systemic

3.4

31.8

159

474

L13

ICPC

Hip symptom/complaint

1.5

31.7

1169

8107

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

31.7

583

3350

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

31.6

1193

8320

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.4

31.6

160

482

F61.0

ICD-10 Finland

Mixed personality disorders

3.8

31.5

139

375

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

31.3

372

1820

G21.8

ICD-10 Finland

Other secondary parkinsonism

+∞

31.3

R11

ICD-10 Finland

Nausea and vomiting

1.8

30.9

569

3269

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

30.8

3529

29879

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.3

30.6

295

1311

R03BA05

ATC

fluticasone; inhalant

1.5

30.6

1253

8885

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.2

30.6

119

287

P74

ICPC

Anxiety disorder/anxiety state

2.5

30.5

244

985

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

30.5

566

3264

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

30.5

3069

25478

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.2

30.5

118

283

R51

ICD-10 Finland

Headache

2.1

30.5

355

1722

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.1

30.4

195

I95.1

ICD-10 Finland

Orthostatic hypotension

2.4

30.3

268

1142

D01

ICPC

Abdominal pain/cramps general

1.7

30.3

730

4550

N07BB01

ATC

disulfiram; oral

2.3

30.2

288

1275

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

30.2

975

6557

N04BB01

ATC

amantadine; oral

3.5

30.1

144

415

K59.0

ICD-10 Finland

Constipation

2.0

30.1

417

2166

G04BD08

ATC

solifenacin; oral

1.8

29.9

515

2898

R03BA01

ATC

beclometasone; inhalant

1.5

29.8

1000

6783

WX002

NOMESCO Finland

Sedation and analgesia

1.4

29.5

1429

10481

J01EA01

ATC

trimethoprim; systemic

1.4

29.5

1817

13931

J45.1

ICD-10 Finland

Nonallergic asthma

1.8

29.5

522

2963

F40.1

ICD-10 Finland

Social phobias

3.3

29.4

153

471

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

29.4

193

696

N05AD01

ATC

haloperidol; systemic

2.6

29.3

224

884

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

29.2

2444

19695

EBA00

NOMESCO Finland

Extraction of tooth

1.4

29.2

2179

17247

M54.3

ICD-10 Finland

Sciatica

1.9

29.1

429

2283

L14

ICPC

Leg/thigh symptom/complaint

1.8

29.1

556

3235

L86

ICPC

Back syndrome with radiating pain

1.9

29.0

419

2214

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

28.9

220

864

N05AH02

ATC

clozapine; systemic

3.6

28.8

135

384

A03FA02

ATC

cisapride; oral, rectal

1.7

28.6

576

3406

N01

ICPC

Headache

1.7

28.5

623

3772

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

28.5

405

2128

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.9

28.4

120

312

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

28.4

418

2227

R03BA08

ATC

ciclesonide; inhalant

1.7

28.3

572

3382

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

28.3

926

6237

N99

ICPC

Neurological disease other

4.0

28.3

117

299

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.8

28.2

517

2967

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.9

28.2

426

2288

3AX01

NOMESCO Finland

14.8

28.2

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.9

28.2

119

310

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

28.0

1926

15017

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

27.9

563

3328

J01DA01

ATC

[U] cefalexin; systemic

1.3

27.8

4534

40072

S29

ICPC

Skin symptom/complaint other

1.5

27.8

1191

8513

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.0

27.8

132

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

27.4

515

2979

D07AC01

ATC

betamethasone; topical

1.3

27.4

2367

19121

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.0

27.3

161

542

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.1

27.3

157

519

M54.1

ICD-10 Finland

Radiculopathy

2.2

27.3

291

1359

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

27.2

2263

18181

A01AB09

ATC

miconazole; local oral

1.7

27.1

636

3930

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.2

27.0

147

469

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

26.9

1861

14508

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

26.9

1736

13379

Z00.0

ICD-10 Finland

General medical examination

1.4

26.8

1278

9322

R25.0

ICD-10 Finland

Abnormal head movements

31.9

26.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

26.6

4324

38094

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.0

26.5

177

M01AX17

ATC

nimesulide; oral

1.4

26.5

1778

13789

M01AH02

ATC

rofecoxib; oral

1.5

26.3

968

6691

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

26.3

443

2472

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

26.2

463

2625

M54.2

ICD-10 Finland

Cervicalgia

1.8

26.1

487

2809

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

6.2

26.0

116

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.1

26.0

144

465

XG466

NOMESCO Finland

Sleep oxymetry

2.3

26.0

248

1100

L29

ICPC

Musculoskeletal sympt/complt other

1.7

25.9

529

3140

AA400

NOMESCO Finland

Electroconvulsive therapy

5.1

25.9

161

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

25.8

1101

7852

SPAT1058

SPAT

PEF monitoring instruction

1.7

25.8

598

3682

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

25.7

795

5279

N05AA01

ATC

chlorpromazine; systemic, rectal

3.7

25.7

113

305

J01MA02

ATC

ciprofloxacin; systemic

1.3

25.7

2764

23001

G23.8

ICD-10 Finland

Other specified degenerative diseases of basal ganglia

261.4

25.7

D11

ICPC

Diarrhoea

1.6

25.7

697

4479

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

25.6

1259

9235

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

25.5

1286

9471

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

7.4

25.5

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

25.4

304

1492

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

25.4

1231

9000

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.8

25.4

170

622

R1250

NOMESCO Finland

Evaluation of functional capability

2.8

25.4

164

587

R74

ICPC

Upper respiratory infection acute

1.4

25.4

1697

13139

M02AA07

ATC

piroxicam; topical

1.3

25.1

2627

21757

R03BB04

ATC

tiotropium bromide; inhalant

1.6

25.1

711

4618

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.8

25.1

416

2309

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

24.9

235

1035

A07AA02

ATC

nystatin; oral

1.8

24.9

466

2692

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.6

24.8

640

4055

N05AC02

ATC

thioridazine; oral

3.0

24.8

146

492

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

24.8

294

1436

R96

ICPC

Asthma

1.6

24.7

620

3900

A06AC51

ATC

ispaghula, combinations; systemic

1.9

24.7

366

1949

A29

ICPC

General symptom/complaint other

1.6

24.7

764

5073

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

24.7

984

6915

R03AC03

ATC

terbutaline; inhalant

1.5

24.7

952

6643

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

24.5

1256

9274

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.3

24.4

242

1091

R4110

NOMESCO Finland

Physiotherapy

1.3

24.3

1844

14555

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

24.2

1180

8633

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

24.1

1363

10240

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

24.0

281

1366

G25.6

ICD-10 Finland

Drug-induced tics and other tics of organic origin

+∞

24.0

SPAT1325

SPAT

Vaccination

1.3

23.9

2531

20958

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

23.9

968

6822

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

23.8

244

1119

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

3.0

23.8

139

466

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.6

23.8

172

659

A02BC04

ATC

rabeprazole; oral

1.7

23.8

566

3511

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

23.8

332

1730

J01FA06

ATC

roxithromycin; oral

1.3

23.8

2833

23835

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.3

23.7

228

1016

A11

ICPC

Chest pain NOS

1.7

23.7

542

3324

R50.9

ICD-10 Finland

Fever, unspecified

1.5

23.7

918

6408

R27.0

ICD-10 Finland

Ataxia, unspecified

6.9

23.6

L16

ICPC

Ankle symptom/complaint

1.6

23.6

670

4356

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.7

23.5

105

288

J01CA08

ATC

pivmecillinam; oral

1.3

23.5

2719

22779

R06AX27

ATC

desloratadine; oral

1.4

23.4

1682

13156

H13

ICPC

Plugged feeling ear

1.4

23.3

1254

9334

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

23.3

951

6712

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.9

23.2

370

2027

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

23.2

478

2842

C10AA05

ATC

atorvastatin; oral

1.3

23.1

2724

22859

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.1

23.1

229

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

23.0

206

886

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

22.9

157

581

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

22.9

1603

12473

ZXA10

NOMESCO Finland

Bilateral

1.4

22.9

1316

9910

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

22.9

1417

10806

J01FA10

ATC

azithromycin; systemic

1.3

22.9

3915

34421

R01AD12

ATC

fluticasone furoate; nasal

1.3

22.9

1830

14540

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

22.8

6664

62712

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

22.8

2363

19488

R4120

NOMESCO Finland

Occupational therapy

1.8

22.7

425

2456

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

22.7

495

2997

SFA00

NOMESCO Finland

Small filling

1.5

22.6

823

5667

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

22.6

690

4561

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.3

22.4

113

342

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.7

22.4

160

610

-1

NOMESCO Finland

1.3

22.4

2105

17114

N06BA04

ATC

methylphenidate; oral

3.1

22.3

123

398

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

22.1

890

6258

D06

ICPC

Abdominal pain localized other

1.7

22.1

524

3249

XF402

NOMESCO Finland

ECG with work load test

1.5

22.0

785

5378

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.4

22.0

1259

9471

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

21.9

1186

8830

F51

ICD-10 Finland

Nonorganic sleep disorders

2.3

21.9

213

956

G24.0

ICD-10 Finland

Drug-induced dystonia

+∞

21.9

H02AB07

ATC

prednisone; oral

1.4

21.8

977

7022

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

21.8

1094

8037

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

21.7

1759

13982

R05FB02

ATC

cough suppressants and expectorants

1.3

21.7

2673

22509

G04CA01

ATC

alfuzosin; oral

1.5

21.7

737

4993

G24.5

ICD-10 Finland

Blepharospasm

80.3

21.7

G04BD07

ATC

tolterodine; oral

1.8

21.6

378

2135

N04BC06

ATC

cabergoline; oral (dopamine agonists)

6.7

21.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

21.5

233

1097

A99

ICPC

Disease/condition unspecnature/site

1.6

21.5

550

3476

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

21.5

1706

13520

A02BA04

ATC

nizatidine; systemic

1.6

21.4

559

3552

K07.60

ICD-10 Finland

Snapping jaw

2.0

21.4

297

1547

P72

ICPC

Schizophrenia

3.0

21.4

123

408

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

21.4

423

2488

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.1

21.3

118

383

SPAT1211

SPAT

Application of soft bandage

1.6

21.3

624

4084

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

21.2

1371

10516

N06AB08

ATC

fluvoxamine; oral

2.3

21.2

204

909

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

21.1

2047

16685

N28

ICPC

Limited function/disability (N)

3.0

21.1

123

414

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

21.1

239

1149

SPAT1360

SPAT

Extensive global examination

1.6

21.0

526

3308

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

20.8

529

3339

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.9

20.8

127

440

C05AA08

ATC

fluocortolone; rectal, topical

1.4

20.7

949

6845

ZXA00

NOMESCO Finland

Right side

1.3

20.7

1895

15318

R01AD01

ATC

beclometasone; nasal

1.4

20.7

985

7160

M02AA10

ATC

ketoprofen; topical

1.4

20.7

1089

8062

U07

ICPC

Urine symptom/complaint other

1.7

20.6

406

2384

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

6.0

20.6

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

20.6

881

6268

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

20.5

4795

43470

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.5

20.4

167

685

K07

ICPC

Swollen ankles/oedema

1.9

20.4

315

1708

W19

ICD-10 Finland

Unspecified fall

1.6

20.4

611

4022

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.7

20.4

246

WX723

NOMESCO Finland

CPAP therapy

2.1

20.4

234

1132

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

20.3

2119

17427

C07AA07

ATC

sotalol; systemic

1.9

20.3

288

1515

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

20.3

1546

12164

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

20.3

1954

15900

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

20.2

206

944

N06AX18

ATC

reboxetine; oral

3.4

20.2

284

SPAT1262

SPAT

Handing over of treatment supplies

1.4

20.2

1260

9606

N05AL01

ATC

sulpiride; systemic

3.0

20.1

121

414

D07AA02

ATC

hydrocortisone; topical

1.5

20.0

848

6020

J20

ICD-10 Finland

Acute bronchitis

1.5

20.0

628

4174

A05

ICPC

Feeling ill

1.8

20.0

349

1971

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

19.9

1217

9242

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.9

19.9

287

1519

D12

ICPC

Constipation

2.1

19.8

241

1192

R49.02

ICD-10 Finland

Spasmodic dysphonia

12.5

19.8

L84

ICPC

Back syndrome without radiat pain

1.9

19.8

288

1530

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

19.7

2896

24844

C07AB02

ATC

metoprolol; systemic

1.3

19.7

1470

11519

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

19.7

567

3694

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

19.6

445

2723

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.5

19.6

615

4091

G24

ICD-10 Finland

Dystonia

200.4

19.6

S22

ICPC

Nail symptom/complaint

1.7

19.4

389

2294

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

7.9

19.4

XA402

NOMESCO Finland

ENMG

2.3

19.4

176

765

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

19.3

376

2200

C10AA07

ATC

rosuvastatin; oral

1.3

19.3

1646

13154

F41.00

ICD-10 Finland

Moderate panic disorder

3.1

19.3

105

338

SPAT1097

SPAT

Recording of ECG

1.4

19.2

1052

7837

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

19.2

194

889

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

19.2

383

2259

L19

ICPC

Muscle symptom/complaint NOS

2.3

19.1

177

776

L60.0

ICD-10 Finland

Ingrowing nail

1.9

19.1

292

1579

IGY02

SPAT

5.1

19.0

119

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

19.0

261

1357

H53.2

ICD-10 Finland

Diplopia

2.1

19.0

207

979

XKC03

NOMESCO Finland

Water cystometry

2.1

19.0

230

1137

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

18.9

223

1088

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

18.9

1179

8976

N06AX17

ATC

milnacipran; oral

3.3

18.8

300

C10AA01

ATC

simvastatin; oral

1.2

18.8

3158

27468

U04

ICPC

Incontinence urine

1.8

18.8

322

1807

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

18.7

269

1423

R21

ICPC

Throat symptom/complaint

1.4

18.7

1117

8442

A97

ICPC

No disease

1.4

18.7

956

7031

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.0

18.7

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

6.3

18.6

R06AE09

ATC

levocetirizine; oral

1.4

18.6

868

6280

L05

ICPC

Flank/axilla symptom/complaint

1.7

18.6

360

2104

N06AA04

ATC

clomipramine; systemic

2.7

18.6

127

473

J31.0

ICD-10 Finland

Chronic rhinitis

1.6

18.5

486

3092

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

7.6

18.5

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

18.5

257

1341

SPAT1043

SPAT

Audiometry

1.5

18.4

731

5121

N76.0

ICD-10 Finland

Acute vaginitis

1.9

18.3

288

1571

Z01.7

ICD-10 Finland

Laboratory examination

1.5

18.3

709

4938

N05BA02

ATC

chlordiazepoxide; systemic

2.3

18.3

163

702

N39.3

ICD-10 Finland

Stress incontinence

1.6

18.3

485

3096

R12

ICD-10 Finland

Heartburn

1.6

18.2

459

2891

N04BC02

ATC

pergolide; oral

44.1

18.2

SPAT1252

SPAT

Overall medication plan or its review

1.6

18.2

484

3091

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

18.2

463

2924

S04

ICPC

Lump/swelling localized

1.5

18.2

590

3953

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

18.1

916

6720

XF606

NOMESCO Finland

Ortostatic test

4.1

18.1

171

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

18.0

536

3519

H02

ICPC

Hearing complaint

1.4

18.0

849

6148

D21

ICPC

Swallowing problem

3.0

18.0

105

355

H01

ICPC

Ear pain/earache

1.5

18.0

632

4314

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

18.0

399

2426

G47.8

ICD-10 Finland

Other sleep disorders

4.5

18.0

140

SPAT1101

SPAT

Orthostatic test

1.8

17.9

322

1840

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

17.9

452

2851

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

17.8

614

4174

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

3.2

17.8

297

UJD02

NOMESCO Finland

Gastroscopy

1.8

17.7

324

1860

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

66.7

17.7

E000001

ATC

1.3

17.7

1313

10265

J02AC02

ATC

itraconazole; systemic

1.4

17.6

1153

8845

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

17.6

479

3081

G54.0

ICD-10 Finland

Brachial plexus disorders

2.4

17.5

152

646

M01AB55

ATC

diclofenac, combinations; oral

1.6

17.5

472

3026

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

17.5

1536

12300

D19

ICPC

Teeth/gum symptom/complaint

1.3

17.4

1567

12593

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

17.4

546

3630

R06.2

ICD-10 Finland

Wheezing

1.8

17.4

278

1528

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

17.4

737

5230

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

17.3

331

1926

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

17.3

105

362

P25

ICPC

Phase of life problem adult

2.0

17.3

222

1126

N04AA01

ATC

trihexyphenidyl; oral

42.0

17.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

17.2

526

3477

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

17.2

830

6039

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.5

17.2

230

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.5

17.1

138

566

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

17.1

355

2116

A03

ICPC

Fever

1.4

17.1

902

6665

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

17.1

602

4109

N05AF01

ATC

flupentixol; systemic

2.6

17.1

127

499

ZX114

NOMESCO Finland

Intramuscular

2.9

17.0

105

369

R33

ICD-10 Finland

Retention of urine

1.6

17.0

485

3156

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

16.8

283

1582

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

16.8

1034

7840

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

16.8

507

3345

M15

ICD-10 Finland

Polyarthrosis

1.7

16.7

331

1948

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

16.7

737

5268

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

16.7

2741

23689

G21.0

ICD-10 Finland

Malignant neuroleptic syndrome

+∞

16.7

N19

ICPC

Speech disorder

3.2

16.6

279

U05

ICPC

Urination problems other

1.8

16.6

306

1762

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

16.5

556

3759

J01MA12

ATC

levofloxacin; systemic

1.3

16.5

1213

9462

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.9

16.5

177

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

16.5

220

1133

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

16.4

1547

12497

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

16.3

1416

11316

D09

ICPC

Nausea

1.9

16.2

237

1263

N05AE05

ATC

lurasidone; oral

8.0

16.2

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

16.2

331

1967

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.6

16.2

118

459

N03AF02

ATC

oxcarbazepine; oral

2.0

16.2

205

1035

SPAT1104

SPAT

Monitoring of emergency patient

1.6

16.2

437

2803

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

16.1

699

4980

J46

ICD-10 Finland

Status asthmaticus

2.1

16.1

193

951

WX780

NOMESCO Finland

Remote monitoring CPAP

1.9

16.1

242

1302

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.4

16.1

137

579

SPAT1281

SPAT

Other administrative function

1.5

16.1

505

3360

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

4.9

16.0

107

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

16.0

675

4785

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

16.0

288

1647

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

16.0

435

2796

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.6

15.9

439

2829

M01AX05

ATC

glucosamine; oral

1.3

15.9

1437

11537

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.2

15.9

267

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

15.8

1547

12553

IHZ05

SPAT

2.8

15.8

352

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.3

15.8

152

682

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

15.8

589

4073

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

15.8

763

5549

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.7

15.7

180

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

15.6

459

3006

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.3

15.6

233

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

15.5

373

2324

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

15.4

274

1558

J34.2

ICD-10 Finland

Deviated nasal septum

1.7

15.4

301

1763

H92.0

ICD-10 Finland

Otalgia

1.7

15.4

296

1728

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

15.4

1515

12298

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

15.4

611

4279

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.6

15.3

381

2392

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.7

15.3

300

1761

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

15.3

1016

7795

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

15.2

626

4414

SPAT1251

SPAT

Organisation of medication

1.8

15.2

244

1347

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.4

15.1

725

5260

XF404

NOMESCO Finland

Ambulatory ECG

1.5

15.1

619

4359

A08

ICPC

Swelling

1.8

15.1

282

1630

Z01.9

ICD-10 Finland

Special examination, unspecified

1.6

15.1

354

2188

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

15.1

221

1178

SPAT1167

SPAT

Insertion of urinary catheter

1.9

15.1

221

1178

T90

ICPC

Diabetes non-insulin dependent

1.3

15.0

1537

12532

N02AA05

ATC

oxycodone; systemic

1.4

15.0

941

7153

U01

ICPC

Dysuria/painful urination

1.5

15.0

469

3116

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

15.0

1326

10608

R41.3

ICD-10 Finland

Other amnesia

2.0

15.0

200

1031

G04BD09

ATC

trospium; oral

2.0

15.0

182

902

SPAT1285

SPAT

Provision of consultation response

1.6

14.9

359

2234

SGA01

NOMESCO Finland

Tooth opening as first aid

1.4

14.9

871

6541

E66.8

ICD-10 Finland

Other obesity

1.7

14.9

298

1759

IBA03

NOMESCO Finland

Psychotherapy evaluation

4.0

14.9

149

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.4

14.9

690

4981

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

14.9

491

3306

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.3

14.9

135

591

M03AX01

ATC

botulinum toxin; parenteral

3.4

14.8

210

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

14.8

219

1172

ZXA05

NOMESCO Finland

Left side

1.3

14.8

1729

14330

D02

ICPC

Abdominal pain epigastric

1.6

14.7

342

2110

N06AA10

ATC

nortriptyline; systemic

2.2

14.7

144

651

A27

ICPC

Fear of other disease NOS

1.8

14.7

273

1579

A01AB04

ATC

amphotericin B; local oral

1.7

14.6

333

2043

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

1.9

14.6

199

1035

P73

ICPC

Affective psychosis

5.4

14.6

E03

ICD-10 Finland

Other hypothyroidism

1.6

14.5

374

2370

R49.08

ICD-10 Finland

Other specified dysphonia

2.3

14.5

137

608

N27

ICPC

Fear of neurological disease other

2.6

14.5

102

388

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.3

14.5

225

R03AC13

ATC

formoterol; inhalant

1.7

14.4

329

2021

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

14.4

504

3438

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.7

14.3

164

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

14.3

372

2364

N05CD02

ATC

nitrazepam; oral

2.4

14.3

119

498

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.0

14.3

186

950

H02AB04

ATC

methylprednisolone; systemic

1.3

14.3

948

7269

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

14.2

723

5300

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

14.2

345

2155

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

14.2

1352

10914

S21

ICPC

Skin texture symptom/complaint

1.4

14.2

805

6018

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.4

14.1

117

487

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

14.1

614

4374

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

14.1

126

546

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.2

14.1

147

684

R30.0

ICD-10 Finland

Dysuria

1.8

14.1

223

1225

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.4

14.1

203

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

14.0

566

3975

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

14.0

632

4532

J01FF01

ATC

clindamycin; systemic

1.3

14.0

1736

14479

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.5

14.0

111

455

N05AD03

ATC

melperone; systemic

2.8

13.9

322

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.1

13.9

152

725

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

13.9

1400

11380

U71

ICPC

Cystitis/urinary infection other

1.6

13.9

383

2471

P28

ICPC

Limited function/disability (P)

3.6

13.9

174

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

3.7

13.9

159

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

13.9

2980

26339

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.7

13.8

267

1564

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

13.8

1314

10608

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

13.8

1430

11672

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

13.7

171

860

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

13.7

2112

18037

M70.7

ICD-10 Finland

Other bursitis of hip

2.0

13.7

173

875

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.8

13.7

227

1265

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.8

13.7

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

13.7

513

3551

N30

ICD-10 Finland

Cystitis

1.5

13.6

457

3084

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

13.6

651

4719

S02

ICPC

Pruritus

1.9

13.6

205

1107

SBB10

NOMESCO Finland

Teeth copy

1.6

13.6

340

2141

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

13.6

161

795

F45.0

ICD-10 Finland

Somatization disorder

4.7

13.6

G25.4

ICD-10 Finland

Drug-induced chorea

+∞

13.5

H50.52

ICD-10 Finland

Exophoria

3.1

13.5

237

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

13.5

884

6764

C01DA14

ATC

isosorbide mononitrate; oral

1.3

13.5

1017

7950

SPAT1139

SPAT

Nutrition survey

1.8

13.4

214

1179

Z29

ICPC

Social problem NOS

2.3

13.4

119

515

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

13.4

884

6769

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.9

13.4

266

H93.1

ICD-10 Finland

Tinnitus

1.6

13.4

391

2560

M54.8

ICD-10 Finland

Other dorsalgia

1.8

13.4

239

1366

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

13.3

974

7573

AA40B

NOMESCO Finland

4.2

13.3

116

L29.9

ICD-10 Finland

Pruritus, unspecified

2.1

13.3

156

764

G04BD11

ATC

fesoterodine; oral

1.9

13.3

203

1103

R4110

SPAT

1.9

13.3

184

963

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.6

13.2

309

1912

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.6

13.2

161

S22.3

ICD-10 Finland

Fracture of rib

1.5

13.2

392

2575

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

13.2

690

5087

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

3.0

13.2

257

R30.1

ICD-10 Finland

Vesical tenesmus

2.3

13.1

125

558

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.2

13.1

138

645

SPAT1284

SPAT

Extensive health certificate

1.9

13.1

181

946

D07AB08

ATC

desonide; topical

1.4

13.1

643

4686

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.1

1742

14627

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

13.1

812

6158

R06AX22

ATC

ebastine; oral

1.3

13.1

1012

7931

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.9

13.1

179

935

H02.3

ICD-10 Finland

Blepharochalasis

1.5

13.1

395

2604

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.8

13.0

294

L04

ICPC

Chest symptom/complaint

1.6

13.0

344

2197

N05AE04

ATC

ziprasidone; systemic

3.9

13.0

133

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

13.0

450

3061

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

13.0

133

618

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.4

13.0

110

466

R26.0

ICD-10 Finland

Ataxic gait

6.0

12.9

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.5

12.9

101

K03.66

ICD-10 Finland

Tooth plaque

1.6

12.9

371

2419

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.1

12.9

120

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

12.9

144

694

SPAT1237

SPAT

Psychotherapy

4.3

12.8

111

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.3

12.8

115

501

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

12.8

128

586

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

12.8

236

1364

K02

ICD-10 Finland

Dental caries

1.5

12.8

395

2618

M19.8

ICD-10 Finland

Other specified arthrosis

1.8

12.8

212

1186

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

12.8

294

1811

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.8

12.8

299

XQ800

NOMESCO Finland

Prick test

1.5

12.7

412

2761

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

12.7

628

4584

H29

ICPC

Ear symptom/complaint other

1.4

12.7

636

4652

SPAT1283

SPAT

Restricted health certificate

1.3

12.7

829

6337

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

12.6

127

583

X58

ICD-10 Finland

Exposure to other specified factors

1.4

12.6

780

5909

E61.1

ICD-10 Finland

Iron deficiency

2.6

12.6

336

K04.0

ICD-10 Finland

Pulpitis

1.5

12.6

481

3340

AA5QN

NOMESCO Finland

32.0

12.6

R52.1

ICD-10 Finland

Chronic intractable pain

3.1

12.5

222

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.4

12.5

100

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

12.5

239

1397

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

12.5

1154

9266

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

12.5

423

2861

3320A

ICD-9 Finland

Parkinson's disease, Paralysis agitans

+∞

12.5

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

+∞

12.5

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

12.5

355

2306

F31.21

ICD-10 Finland

Bipolar disorder, manic episode with mood incongruent psychotic symptoms

8.2

12.5

N06BA07

ATC

modafinil; oral

5.9

12.5

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

12.5

399

2665

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

12.5

433

2946

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.1

12.5

119

P98

ICPC

Psychosis NOS/other

4.1

12.5

119

S80.0

ICD-10 Finland

Contusion of knee

1.5

12.5

369

2424

ICD-10 Finland

2.0

12.5

165

850

S01

ICPC

Pain/tenderness of skin

1.7

12.4

266

1607

F22.0

ICD-10 Finland

Delusional disorder

2.4

12.4

101

420

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.4

12.4

101

SPAT1050

SPAT

Extensive neurological examination

2.0

12.4

150

748

J01MA06

ATC

norfloxacin; oral

1.3

12.4

869

6712

R31

ICD-10 Finland

Unspecified haematuria

1.4

12.4

632

4639

F33

ICD-10 Finland

Recurrent depressive disorder

2.4

12.4

100

414

R4130

NOMESCO Finland

Speech therapy

2.1

12.4

135

644

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

12.3

532

3785

R49.01

ICD-10 Finland

Functional dysphonia

1.9

12.3

181

971

N05AB01

ATC

dixyrazine; systemic

2.7

12.3

322

H26.4

ICD-10 Finland

After-cataract

1.4

12.3

601

4375

R06AX13

ATC

loratadine; oral

1.3

12.3

876

6784

M77.4

ICD-10 Finland

Metatarsalgia

1.6

12.3

310

1957

S20.2

ICD-10 Finland

Contusion of thorax

1.7

12.3

274

1674

R25.3

ICD-10 Finland

Fasciculation

5.0

12.2

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

8.9

12.2

K04.08

ICD-10 Finland

Other specified pulpit

1.6

12.2

322

2055

L84

ICD-10 Finland

Corns and callosities

1.8

12.2

207

1167

F06.7

ICD-10 Finland

Mild cognitive disorder

1.9

12.2

167

873

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.6

12.2

350

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

3.6

12.2

152

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.4

12.1

404

P15

ICPC

Chronic alcohol abuse

2.0

12.1

147

731

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

15.9

12.1

G01AF05

ATC

econazole; vaginal

1.5

12.1

446

3077

F05.9

ICD-10 Finland

Delirium, unspecified

2.2

12.1

121

556

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

12.1

633

4669

R01AD05

ATC

budesonide; nasal

1.5

12.0

465

3237

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

12.0

216

1236

A01AB10

ATC

natamycin; local oral

1.9

12.0

176

943

N89

ICPC

Migraine

2.0

12.0

140

689

R07

ICPC

Sneezing/nasal congestion

1.6

12.0

326

2098

R03AK11

ATC

formoterol and fluticasone; inhalant

2.0

12.0

157

807

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.2

12.0

115

520

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

11.9

1470

12221

R39.1

ICD-10 Finland

Other difficulties with micturition

1.9

11.9

181

980

C09CA01

ATC

losartan; oral

1.2

11.9

1578

13228

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.2

11.9

117

534

I95.9

ICD-10 Finland

Hypotension, unspecified

2.5

11.8

379

F29

ICPC

Eye symptom/complaint other

1.5

11.8

475

3334

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

11.8

273

1687

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

11.8

449

3119

R15

ICD-10 Finland

Faecal incontinence

1.9

11.8

180

979

A07DA03

ATC

loperamide; oral

1.7

11.8

225

1317

K08.80

ICD-10 Finland

Toothache NOS

1.5

11.7

421

2884

VALMI

NOMESCO Finland

1.2

11.7

1444

12000

WX722

NOMESCO Finland

PEEP

1.6

11.7

290

1820

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

5.4

11.7

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

11.7

315

R75

ICPC

Sinusitis acute/chronic

1.7

11.7

248

1497

K04

ICPC

Palpitations/awareness of heart

1.6

11.6

313

2008

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

11.6

710

5367

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.2

11.6

1700

14403

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.6

11.5

290

1831

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

11.5

275

1709

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

11.5

208

1197

H02AA02

ATC

fludrocortisone; oral

3.3

11.5

170

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.6

11.5

305

G24.2

ICD-10 Finland

Idiopathic nonfamilial dystonia

+∞

11.5

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

11.4

381

2572

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.6

11.4

289

1828

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

11.4

183

1012

B01AC04

ATC

clopidogrel; oral

1.3

11.4

1009

8052

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

11.4

1667

14114

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.7

11.3

210

1217

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

11.3

528

3814

K29

ICPC

Cardiovascular sympt/complt other

1.6

11.3

268

1666

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

11.3

311

2010

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.5

11.3

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.8

11.2

249

M35.7

ICD-10 Finland

Hypermobility syndrome

2.6

11.2

312

R83

ICPC

Respiratory infection other

1.3

11.2

1242

10195

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

11.2

1567

13210

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

11.1

326

2139

C08CA01

ATC

amlodipine; oral

1.2

11.1

2436

21454

G01AA10

ATC

clindamycin; vaginal

1.3

11.1

826

6436

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.6

11.1

277

1747

C01CA01

ATC

etilefrine; systemic

3.2

11.0

181

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

11.0

551

4030

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

11.0

532

3866

G43

ICD-10 Finland

Migraine

1.8

11.0

200

1153

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

11.0

691

5246

Z72.2

ICD-10 Finland

Drug use

5.2

11.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.5

11.0

338

2242

C03DA01

ATC

spironolactone; oral

1.4

11.0

662

4999

S20

ICPC

Corn/callosity

2.1

10.9

127

624

R07.0

ICD-10 Finland

Pain in throat

1.5

10.9

325

2137

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

10.9

2344

20597

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

10.9

504

3634

SPAT1244

SPAT

Occupational therapy

2.6

10.9

281

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

10.8

746

5746

R41.0

ICD-10 Finland

Disorientation, unspecified

1.8

10.8

180

1009

R44.1

ICD-10 Finland

Visual hallucinations

4.0

10.8

106

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.7

10.8

276

B01AA03

ATC

warfarin; systemic

1.2

10.8

1314

10903

G03DB01

ATC

dydrogesterone; oral

1.3

10.8

691

5268

F32.8

ICD-10 Finland

Other depressive episodes

2.4

10.7

363

A46

ICD-10 Finland

Erysipelas

1.3

10.7

858

6753

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

6.1

10.7

R06.4

ICD-10 Finland

Hyperventilation

2.2

10.7

101

455

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.5

10.7

325

2150

K08.3

ICD-10 Finland

Retained dental root

1.5

10.6

400

2771

D07AD01

ATC

clobetasol; topical

1.3

10.6

941

7508

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.9

10.6

220

K85

ICPC

Elevated blood pressure

1.3

10.6

949

7580

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

10.6

356

2408

SPAT1235

SPAT

Mental health, emotional support

3.4

10.6

149

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.3

10.6

160

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

10.5

403

2802

R40.0

ICD-10 Finland

Somnolence

5.3

10.5

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

5.7

10.5

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

3.9

10.5

109

C01CA24

ATC

epinephrine; parenteral

1.5

10.5

317

2095

N03AX14

ATC

levetiracetam; systemic

1.9

10.5

151

806

F60.7

ICD-10 Finland

Dependent personality disorder

4.0

10.4

100

SPAT1051

SPAT

Guidance regarding sleep disorders

2.3

10.4

426

R03BC03

ATC

nedocromil; inhalant

1.4

10.4

431

3042

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.3

10.4

837

6591

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

10.4

252

1580

R44.3

ICD-10 Finland

Hallucinations, unspecified

4.1

10.4

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.4

10.4

436

3089

A60

ICPC

General and Unspecified, Result test/procedure

1.6

10.4

258

1627

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

2.9

10.3

206

G90.3

ICD-10 Finland

Multi-system degeneration

32.5

10.3

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.4

10.3

456

3261

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.8

10.3

162

893

SCA02

NOMESCO Finland

Analysis and advice of nutrition with regard to dentistry

1.4

10.3

532

3916

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

10.3

214

1285

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

10.3

105

488

IER01

NOMESCO Finland

Psychoeducation, group

4.6

10.2

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

10.2

518

3797

L09

ICPC

Arm symptom/complaint

1.6

10.2

257

1626

S09

ICPC

Infected finger/toe

1.8

10.2

178

1012

S01.0

ICD-10 Finland

Open wound of scalp

1.4

10.2

417

2940

H82

ICPC

Vertiginous syndrome

2.1

10.2

107

503

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

10.2

765

5966

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

10.2

211

1266

N02AC04

ATC

dextropropoxyphene; oral

1.6

10.1

236

1462

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

10.1

316

2105

D01AE16

ATC

amorolfine; topical

1.3

10.1

731

5672

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

10.1

583

4373

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

10.1

129

658

K11.70

ICD-10 Finland

Hypoptyalism

3.5

10.0

129

R5599

NOMESCO Finland

Other rehabilitation service

1.8

10.0

167

937

C10AA04

ATC

fluvastatin; oral

1.4

10.0

566

4229

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

10.0

366

2525

M01AX01

ATC

nabumetone; oral

1.6

10.0

265

1697

AN1

Coronary angiography

1.3

10.0

761

5951

F05

ICPC

Visual disturbance other

1.8

9.9

161

897

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.8

9.9

229

M75

ICD-10 Finland

Shoulder lesions

1.6

9.9

247

1555

H02AB02

ATC

dexamethasone; systemic

0.7

9.9

351

4892

A07EA06

ATC

budesonide; oral, local oral

1.7

9.9

188

1099

T82

ICPC

Obesity

1.7

9.9

186

1084

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

9.9

330

2232

N07BA03

ATC

varenicline; oral

1.6

9.9

258

1647

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

9.9

584

4392

IHZ07

SPAT

4.4

9.9

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

9.9

186

1088

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.5

9.8

374

2602

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.2

9.8

153

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.5

9.8

382

2667

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.7

9.8

216

1322

IEY01

NOMESCO Finland

Psychoeducation, individual

3.6

9.7

117

IGV01

NOMESCO Finland

Psychiatric network contact

3.8

9.7

107

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.6

9.7

253

1614

K78

ICPC

Atrial fibrillation/flutter

1.4

9.7

485

3548

G93.3

ICD-10 Finland

Postviral fatigue syndrome

4.8

9.7

S70.0

ICD-10 Finland

Contusion of hip

1.7

9.7

200

1198

J01DA08

ATC

[U] cefaclor; oral

1.4

9.7

567

4258

DHB50

NOMESCO Finland

Turbinoplasty

1.9

9.7

141

756

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

9.7

302

2011

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.1

9.7

111

544

SPAT1336

SPAT

Request for examination

1.6

9.6

231

1441

D25

ICPC

Abdominal distension

2.1

9.6

108

524

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.8

9.6

167

949

R29

ICPC

Respiratory symptom/complaint other

1.5

9.6

355

2453

XA421

NOMESCO Finland

Nocturnal polygraphy

4.1

9.6

IHZ04

SPAT

4.1

9.6

K27

ICPC

Fear cardiovascular disease other

2.6

9.6

260

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.6

9.6

271

N02AJ13

ATC

tramadol and paracetamol; systemic

2.0

9.6

119

603

J05AB01

ATC

aciclovir; systemic

1.2

9.6

1267

10597

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

9.5

293

1947

S94

ICPC

Ingrowing nail

2.2

9.5

438

R01AX03

ATC

ipratropium bromide; nasal

1.9

9.5

140

756

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.3

9.5

650

5001

Z08

ICPC

Social welfare problem

2.5

9.5

298

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.3

9.5

347

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

9.5

382

2685

P58

ICPC

Psychological, Therapeutic counselling/listening

2.3

9.5

368

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.4

9.5

564

4248

AAG10

NOMESCO Finland

Stereotactic intracranial destruction of nucleus or nerve tract

100.1

9.4

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

9.4

391

2765

N02CC04

ATC

rizatriptan; oral

1.5

9.4

288

1911

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

6.6

9.4

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.4

9.4

126

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.0

9.4

120

616

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

+∞

9.4

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

4.6

9.3

D01AC02

ATC

miconazole; topical

1.4

9.3

456

3323

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

9.3

1364

11527

R03AC12

ATC

salmeterol; inhalant

1.5

9.3

269

1763

SPAT1106

SPAT

Acupuncture

2.8

9.3

199

G04CB02

ATC

dutasteride; oral

1.5

9.3

357

2487

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

3.5

9.3

122

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

9.3

454

3312

A10BH01

ATC

sitagliptin; oral

1.3

9.3

574

4349

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

2.9

9.3

187

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

3.7

9.3

107

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

4.8

9.2

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

9.2

257

1667

D03

ICPC

Heartburn

1.7

9.2

185

1100

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

9.2

369

2589

ACC53

NOMESCO Finland

Release of ulnar nerve

2.3

9.2

358

WX320

NOMESCO Finland

Spinalanesthesy

1.2

9.2

1438

12231

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

6.4

9.2

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.5

9.2

283

G01AF04

ATC

miconazole; vaginal

1.5

9.2

263

1718

X72

ICPC

Genital candidiasis female

2.9

9.2

181

J45.8

ICD-10 Finland

Mixed asthma

1.7

9.2

181

1070

N05AH05

ATC

asenapine; oral

7.3

9.2

A02BA03

ATC

famotidine; systemic

1.6

9.2

233

1480

F31.2

ICD-10 Finland

Bipolar affective disorder, current episode manic with psychotic symptoms

5.2

9.2

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.3

9.2

611

4681

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.0

9.2

116

593

B01AB05

ATC

enoxaparin; parenteral

1.2

9.2

1994

17494

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

2.6

9.2

259

M01AH03

ATC

valdecoxib; oral

1.4

9.2

378

2672

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.5

9.1

285

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.5

9.1

276

1829

L99

ICPC

Musculoskeletal disease other

2.0

9.1

118

609

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.5

9.1

1730

A85

ICPC

Adverse effect medical agent

2.5

9.1

286

F60.5

ICD-10 Finland

Anankastic personality disorder

2.6

9.1

236

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

9.1

416

130

Kela drug reimbursment

Malignant tumour

0.7

9.1

256

3705

U13

ICPC

Bladder symptom/complaint other

1.7

9.1

184

1101

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.5

9.1

347

2418

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

2.9

9.1

177

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

9.1

467

3438

A10BA02

ATC

metformin; oral

1.2

9.0

1787

15540

R25

ICD-10 Finland

Abnormal involuntary movements

15.6

9.0

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.7

9.0

174

1023

XCK00

NOMESCO Finland

Perimetry

1.4

9.0

412

2967

-50

ICPC

Medication/prescr/renewal

1.5

9.0

262

1717

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

9.0

121

632

IGY99

SPAT

3.4

9.0

120

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

9.0

427

3096

F44.4

ICD-10 Finland

Dissociative motor disorders

9.0

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.5

9.0

264

B03BA03

ATC

hydroxocobalamin; parenteral

1.5

9.0

343

2390

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

9.0

251

1634

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

1.9

9.0

121

635

B07.9

ICD-10 Finland

Verruca simplex

1.7

9.0

177

1049

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

8.9

354

2481

C10AX09

ATC

ezetimibe; oral

1.3

8.9

662

5154

N05

ICPC

Tingling fingers/feet/toes

2.3

8.9

340

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

8.9

442

3228

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

8.9

252

1643

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.4

8.9

121

N07CA01

ATC

betahistine; oral

1.4

8.9

458

3368

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.6

8.9

217

1364

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

8.9

373

2646

J01FA09

ATC

clarithromycin; systemic

1.2

8.9

1960

17206

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.0

8.8

160

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

8.8

100

489

R23

ICPC

Voice symptom/complaint

1.9

8.8

118

617

SPAT1238

SPAT

Brief therapy

2.2

8.8

409

EBA30

NOMESCO Finland

Excision of root of tooth

1.5

8.8

309

2114

R09

ICPC

Sinus symptom/complaint

1.4

8.8

401

2889

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

8.8

156

897

F48.0

ICD-10 Finland

Neurasthenia

4.9

8.8

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

3.6

8.8

102

J01FA01

ATC

erythromycin; systemic

1.3

8.8

752

5973

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

2.7

8.8

219

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

8.8

441

3231

XA420

NOMESCO Finland

Extensive sleep examination

2.4

8.8

299

X15

ICPC

Vaginal symptom/complaint other

1.7

8.8

156

899

B81

ICPC

Anaemia vit B12/folate deficiency

1.6

8.7

231

1480

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.5

8.7

256

1683

S06

ICPC

Rash localized

1.5

8.7

328

2275

I20.09

ICD-10 Finland

Unstable angina

1.4

8.7

344

2413

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

8.7

195

1197

XG474

NOMESCO Finland

Exhalation nntrogen oxide

1.7

8.7

157

907

Z50.1

ICD-10 Finland

Other physical therapy

1.5

8.7

322

2227

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

8.7

448

3299

M43.0

ICD-10 Finland

Spondylolysis

2.1

8.7

474

N05AF05

ATC

zuclopenthixol; systemic

2.6

8.7

224

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

8.6

116

606

N02CC05

ATC

almotriptan; oral

1.7

8.6

183

1109

SPAT1377

SPAT

Polysomnography

1.7

8.6

181

1092

H81.3

ICD-10 Finland

Other peripheral vertigo

1.7

8.6

162

948

F51.1

ICD-10 Finland

Nonorganic hypersomnia

7.6

8.6

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.6

8.6

199

1232

G44.0

ICD-10 Finland

Cluster headache syndrome

2.6

8.6

240

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.8

8.6

151

867

KCV04

NOMESCO Finland

Distension of bladder with fluid

2.4

8.6

306

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.1

8.6

434

WZC00

SPAT

1.6

8.6

220

1403

F10.24

ICD-10 Finland

Alcohol depence active use

2.3

8.6

347

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

8.6

111

572

K05.30

ICD-10 Finland

Periodontitis complex

1.3

8.6

711

5622

C08CA05

ATC

nifedipine; systemic

1.4

8.6

388

2794

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.2

8.5

349

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.5

8.5

244

1595

R20.0

ICD-10 Finland

Anaesthesia of skin

3.1

8.5

148

D10AX03

ATC

azelaic acid; topical

1.5

8.5

292

1992

XCK10

NOMESCO Finland

Photography of fundus of eye

1.3

8.5

612

4750

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

8.4

151

870

SPAT1081

SPAT

Cardiorespiratory global assessment

1.4

8.4

360

2563

N18

ICPC

Paralysis/weakness

2.0

8.4

106

542

H57.1

ICD-10 Finland

Ocular pain

1.7

8.4

165

976

C10AC01

ATC

colestyramine; oral

1.7

8.4

156

908

L29.8

ICD-10 Finland

Other pruritus

2.3

8.4

304

R81

ICPC

Pneumonia

1.6

8.4

192

1188

UJH02

NOMESCO Finland

Anoscopy

1.5

8.4

247

1626

I50

ICD-10 Finland

Heart failure

1.6

8.3

185

1136

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

7.8

8.3

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

8.3

309

2140

G24.1

ICD-10 Finland

Idiopathic familial dystonia

+∞

8.3

N04BC07

ATC

apomorphine; parenteral

+∞

8.3

3332A

ICD-9 Finland

Other extrapyramidal disease and abnormal movement disorders, Myoclonus

+∞

8.3

EB1AA

SPAT

1.5

8.3

253

1680

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.6

8.3

217

1388

D18

ICPC

Change in faeces/bowel movements

1.8

8.3

124

676

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

8.3

164

974

K80

ICPC

Cardiac arrhythmia NOS

1.4

8.3

445

3298

R44.0

ICD-10 Finland

Auditory hallucinations

3.9

8.3

F61

ICD-10 Finland

Mixed and other personality disorders

3.9

8.3

SPAT1265

SPAT

Breathalyser

2.7

8.3

195

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.5

8.3

233

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.3

8.3

491

3700

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.5

8.3

237

1551

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

8.3

540

4130

Z97.2

ICD-10 Finland

Presence of dental prosthetic device (complete)(partial)

1.7

8.3

160

943

F43.00

ICD-10 Finland

Acute stress reaction mild

1.9

8.3

109

568

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

2.3

8.3

309

M01AB01

ATC

indometacin; systemic, rectal

1.4

8.2

468

3501

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

8.2

167

1000

E000006

ATC

1.4

8.2

410

3002

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

8.2

522

3977

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

8.2

443

3290

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

8.2

1467

12632

R49.03

ICD-10 Finland

Atrophic dysphonia

2.3

8.2

304

S01GX08

ATC

ketotifen; ophthalmic

1.6

8.1

188

1169

J01FA15

ATC

telithromycin; oral

1.3

8.1

572

4423

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.5

8.1

241

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

8.1

710

5656

OAB44

SPAT

1.6

8.1

184

1136

N06AA22

ATC

2.9

8.1

163

S10

ICPC

Boil/carbuncle

1.5

8.1

290

1993

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.2

8.1

370

J01AA07

ATC

tetracycline; systemic

1.3

8.1

807

6533

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.0

8.1

103

528

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

8.1

561

4326

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

8.1

247

1643

R06AX26

ATC

fexofenadine; oral

1.4

8.1

341

2423

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.3

8.1

503

3817

Z00.8

ICD-10 Finland

Other general examinations

1.4

8.1

385

2798

R5110

SPAT

1.7

8.0

151

884

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.6

8.0

185

1146

F25.2

ICD-10 Finland

Schizoaffective disorder, mixed type

4.8

8.0

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

8.9

8.0

P18

ICPC

Medication abuse

3.5

8.0

100

I84

ICD-10 Finland

Hemorrhoids

1.7

8.0

163

978

D07AC13

ATC

mometasone; topical

1.2

8.0

1788

15693

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.7

8.0

145

839

I45.9

ICD-10 Finland

Conduction disorder, unspecified

2.4

8.0

255

SPAT1172

SPAT

Guidance concerning hydration

1.8

8.0

136

775

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.2

7.9

122

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.3

7.9

483

3655

B18.2

ICD-10 Finland

Chronic viral hepatitis C

2.7

7.9

196

183

Kela drug reimbursment

Lamotrigin and topiramate

2.6

7.9

213

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

1.7

7.9

157

935

E86

ICD-10 Finland

Volume depletion

1.8

7.9

130

732

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

2.2

7.9

347

L57.0

ICD-10 Finland

Actinic keratosis

1.3

7.9

617

4839

G50.1

ICD-10 Finland

Atypical facial pain

1.9

7.9

106

556

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.3

7.9

531

4076

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.0

7.9

501

M76.0

ICD-10 Finland

Gluteal tendinitis

1.9

7.9

104

543

J01MA14

ATC

moxifloxacin; systemic

1.3

7.9

505

3853

K03.00

ICD-10 Finland

Approximal wear

1.5

7.9

264

1794

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

5.1

7.8

Z60.8

ICD-10 Finland

Other problems related to social environment

5.1

7.8

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.7

7.8

184

G43.3

ICD-10 Finland

Complicated migraine

2.2

7.8

330

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

5.7

7.8

Z72.0

ICD-10 Finland

Tobacco use

1.8

7.8

123

682

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

7.8

807

6561

M77.1

ICD-10 Finland

Lateral epicondylitis

1.4

7.8

344

2463

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

7.8

802

6515

TAC99

NOMESCO Finland

Other blockade for chronic pain

2.8

7.8

169

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.8

7.8

169

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

7.8

162

977

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

7.7

536

4133

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.4

7.7

307

2157

C09CA06

ATC

candesartan; oral

1.2

7.7

1303

11152

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

2.8

7.7

170

ACC51

NOMESCO Finland

Release of median nerve

1.4

7.7

411

3044

F60.8

ICD-10 Finland

Other specific personality disorders

3.1

7.7

125

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

3.6

7.7

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.8

7.7

132

754

M05BA04

ATC

alendronic acid; oral

1.3

7.7

524

4032

ZYC01

SPAT

1.5

7.7

288

2002

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

2.1

7.7

415

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

7.7

1096

9229

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.3

7.7

549

4253

N94.1

ICD-10 Finland

Dyspareunia

2.6

7.7

212

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

7.7

503

3850

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

7.7

202

1297

M77.9

ICD-10 Finland

Enthesopathy, unspecified

1.7

7.7

151

899

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.6

919

7598

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.4

7.6

307

2163

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

2.1

7.6

373

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.3

7.6

296

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

7.6

358

2594

207

Kela drug reimbursment

Chronic arrhythmias

1.2

7.6

916

7572

R08

ICPC

Nose symptom/complaint other

1.6

7.6

166

1017

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

2.6

7.6

196

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.4

7.6

359

2604

Z50.5

ICD-10 Finland

Speech therapy

2.2

7.6

320

R78

ICPC

Acute bronchitis/bronchiolitis

1.8

7.6

125

704

F32.0

ICD-10 Finland

Mild depressive episode

1.8

7.6

121

673

K58

ICD-10 Finland

Irritable bowel syndrome

1.8

7.6

123

689

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.3

7.6

290

N06BA12

ATC

lisdexamfetamine; oral

4.9

7.6

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

2.3

7.5

271

C05AA01

ATC

hydrocortisone; rectal, topical

1.4

7.5

311

2201

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

3.1

7.5

122

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.4

7.5

385

2833

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

7.5

1281

10972

R01AC01

ATC

cromoglicic acid; nasal

1.6

7.5

176

1097

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

1.6

7.5

181

1139

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

7.5

223

1475

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.1

7.5

406

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.1

7.5

406

R01AD11

ATC

triamcinolone; nasal

1.3

7.5

489

3741

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.3

7.5

657

5235

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.4

7.4

408

3037

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

7.4

223

1480

SPAT1210

SPAT

Application of cast or individual aid

1.5

7.4

239

1607

R99

ICPC

Respiratory disease other

1.9

7.4

512

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.4

7.4

300

2118

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

3.7

7.4

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.6

7.4

190

1214

F01

ICPC

Eye pain

1.7

7.4

145

862

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.2

7.4

319

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.5

7.4

213

1401

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.5

7.4

234

1571

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.3

7.4

532

4128

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

7.4

522

4043

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

7.4

143

849

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.6

7.4

178

1120

X14

ICPC

Vaginal discharge

2.0

7.4

437

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

2.8

7.3

158

-31

ICPC

Medical examin/health eval partial

1.4

7.3

409

3054

SPAT1168

SPAT

Catheterisation training

3.0

7.3

130

K02

ICPC

Pressure/tightness of heart

1.7

7.3

139

818

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5425

33248

2.48

307.65

3.4

2.9

112.7

135.0

ug/l

12.11

4928

30579

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5145

33850

2.14

277.16

2.3

2.0

95.8

95.4

pmol/l

0.24

2750

17285

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4023

24581

2.11

257.73

2.4

2.1

180.7

215.7

u/l

1.81

3763

22971

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5728

40979

2.01

225.39

6.5

6.7

1.2

mmol/l

1.28

4889

34475

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5314

37142

1.98

222.39

6.0

1.2

mmol/l

0.90

4820

33488

(3021960) Folate [Moles/volume] in Serum or Plasma

3217

19256

2.02

206.88

1.6

1.5

20.4

20.5

nmol/l

0.05

2759

16356

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7505

60215

2.19

203.07

5.0

4.0

14.9

pmol/l

0.56

6855

54470

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3360

20691

1.97

197.02

2.4

2.3

2.8

3.0

mg/l

3.82

2829

17661

(3013707) Erythrocyte sedimentation rate by Westergren method

7338

58805

2.10

192.44

4.7

4.2

12.0

13.0

mm/h

6.97

6778

54217

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8450

71927

2.62

188.32

6.3

4.8

1.9

2.1

mu/l

4.19

7802

65484

(3015377) Calcium [Moles/volume] in Serum or Plasma

4130

27666

1.87

184.13

2.8

3.4

2.4

mmol/l

0.39

3534

23883

(3019309) Folate [Moles/volume] in Red Blood Cells

2713

15948

1.98

178.63

1.9

1.8

1204.3

1161.2

nmol/l

1.39

2054

11945

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7486

61589

2.03

165.71

7.5

7.6

76.8

78.9

u/l

4.24

7045

57839

(3031040) Bacteria [#/volume] in Urine by Automated count

6688

53133

1.88

162.51

6.1

4.6

1730.1

1751.7

e6/l

0.01

753

(3024561) Albumin [Mass/volume] in Serum or Plasma

4882

35302

1.79

162.15

4.3

4.8

35.7

35.2

g/l

9.26

4530

32636

(3018418) pH of Serum or Plasma

3613

24420

1.78

146.70

3.9

4.1

7.4

0.27

577

4650

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2243

13196

1.92

142.13

2.6

3.2

0.8

mmol/l

5.57

2045

12296

(3013826) Glucose [Moles/volume] in Serum or Plasma

5978

47217

1.72

133.02

5.2

4.7

6.6

6.8

mmol/l

5.45

5621

44146

(3037467) Urinalysis macro (dipstick) panel - Urine

6727

55008

1.77

131.18

5.4

4.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4498

33277

1.67

124.88

2.4

2.2

78.0

78.2

nmol/l

0.18

3997

29646

(3022948) Iron [Moles/volume] in Serum or Plasma

2144

12939

1.85

122.97

2.4

2.5

13.7

12.7

umol/l

8.23

1947

11945

(3013115) Eosinophils [#/volume] in Blood

5290

40989

1.66

121.13

6.3

6.0

0.2

e9/l

1.08

4636

35723

(3006315) Basophils [#/volume] in Blood

5146

39733

1.65

118.25

5.9

5.8

0.0

e9/l

0.43

4421

34078

(3001604) Monocytes [#/volume] in Blood

5121

39529

1.64

117.48

5.9

5.8

0.6

e9/l

3.84

4409

33894

(3019550) Sodium [Moles/volume] in Serum or Plasma

8883

80794

2.60

113.62

22.2

17.5

139.6

mmol/l

0.63

8736

78785

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5348

41960

1.63

112.93

5.3

6.2

10.8

11.5

umol/l

5.44

5027

39746

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8682

78227

2.32

112.59

19.1

15.1

21.9

24.3

mg/l

10.08

7300

62636

(3023103) Potassium [Moles/volume] in Serum or Plasma

8890

80987

2.59

111.48

22.4

17.6

4.0

mmol/l

0.07

8729

78820

(3019198) Lymphocytes [#/volume] in Blood

5202

40615

1.62

111.39

6.0

5.8

1.9

e9/l

0.12

4572

35492

(3009466) Valproate [Moles/volume] in Serum or Plasma

356

977

3.75

111.08

6.1

4.7

390.4

357.2

umol/l

3.75

319

823

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2643

17569

1.70

105.97

1.7

20837600.9

33613649.9

pmol/l

0.73

2174

14411

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2372

15311

1.73

105.89

2.8

3.1

2.4

2.5

mmol/l

5.15

2057

13348

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1956

11987

1.80

104.40

2.4

2.5

2.4

2.3

g/l

7.87

1776

11056

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4133

30953

1.59

101.81

4.6

3.8

45.4

84.3

ng/l

1.02

2953

21876

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2500

16527

1.70

101.54

1.3

1.5

1.8

u/ml

0.60

637

4361

(3013650) Neutrophils [#/volume] in Blood by Automated count

5693

46001

1.60

100.92

8.8

9.1

4.2

4.1

e9/l

0.23

4986

40001

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3495

25218

1.61

100.20

2.7

2.6

56.2

58.2

u/l

1.38

3183

23192

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6056

49975

1.59

95.27

3.7

3.1

46.6

49.7

u/l

1.94

5611

46146

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1412

8098

1.87

92.37

2.0

1.7

1.5

2.41

1223

7016

(3035350) Ketones [Presence] in Urine by Test strip

4903

38862

1.54

89.77

4.6

3.8

0.0

estimate

1.34

865

7169

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

997

5131

2.05

89.36

2.5

2.4

37.8

24.4

au/ml

1.26

261

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8083

72194

1.82

89.21

6.9

6.0

40.1

40.0

mmol/mol

0.12

7485

66346

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

474

1790

2.73

86.40

1.2

1.3

589.5

532.9

mg/l

0.35

442

1700

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

922

4668

2.08

86.24

1.3

56.4

51.1

au/ml

0.18

207

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

172

325

5.37

86.16

13.5

11.2

0.6

mmol/l

0.33

154

300

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1784

11232

1.72

84.50

2.5

2.6

22.7

22.2

0.66

1493

9536

(3021601) Nitrite [Presence] in Urine by Test strip

4886

38998

1.52

84.45

5.9

5.1

0.0

estimate

0.80

891

7233

(3026008) Bacteria identified in Urine by Culture

3431

25398

1.55

84.00

3.7

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2672

18697

1.60

83.56

4.6

3.7

—

(42870588) Differential panel, method unspecified - Blood

3637

27302

1.54

83.38

5.6

5.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8366

75896

1.88

82.52

5.6

4.7

6.0

mmol/l

0.28

7652

68699

(3009261) Glucose [Presence] in Urine by Test strip

4917

39421

1.51

82.33

4.7

3.8

0.0

estimate

0.18

868

7085

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1239

7092

1.86

80.74

2.1

2.2

364.3

376.1

nmol/l

1.28

1132

6494

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

423

1566

2.78

80.04

1.2

1.3

3.8

mmol/l

0.02

392

1466

(40761511) CBC panel - Blood by Automated count

8736

80728

2.06

76.82

17.8

14.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2002

13303

1.64

76.28

2.0

1.8

—

(3022096) Basophils/100 leukocytes in Blood

4525

36054

1.49

75.40

6.1

0.7

0.06

4167

33462

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2479

17396

1.58

75.07

1.8

1.7

1.1

1.3

mg/l

1.10

1862

13356

(3019069) Monocytes/100 leukocytes in Blood

4659

37383

1.48

74.68

6.4

6.3

8.6

8.7

1.98

4293

34833

(3006504) Eosinophils/100 leukocytes in Blood

4635

37162

1.48

74.52

6.1

6.0

2.8

2.9

0.37

4263

34456

(36304419) Bacteria [Presence] in Urine

2990

21962

1.53

73.37

3.5

3.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

410

1566

2.69

72.97

1.3

1.5

661.9

1335.6

e6/l

1.30

315

1279

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3258

24397

1.51

72.84

3.2

3.1

1271.7

1539.1

ng/l

2.19

2776

21089

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

409

1565

2.69

72.53

1.3

1.4

8.9

35.3

e6/l

2.07

292

1218

(3002030) Lymphocytes/100 leukocytes in Blood

4730

38271

1.47

71.37

6.2

6.1

27.6

27.5

0.21

4340

35447

(3018010) Neutrophils/100 leukocytes in Blood

4670

37724

1.47

70.85

6.0

5.9

57.6

0.03

4307

35084

(3018095) Leukocytes [#/volume] in Urine

3711

28658

1.48

70.79

4.4

3.8

94.9

103.7

e6/l

0.19

2708

20359

(3023368) Bacteria identified in Blood by Culture

2996

22231

1.51

69.10

4.6

4.3

—

(3019150) Specific gravity of Urine by Refractometry

2408

17084

1.55

68.31

5.4

4.2

1.0

kg/l

0.07

345

2641

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1965

13314

1.60

68.09

1.3

30.5

34.6

iu/ml

0.67

570

4145

(3007164) IgA [Mass/volume] in Serum or Plasma

2097

14459

1.58

67.34

1.5

2.3

2.5

g/l

5.37

1161

8576

(3032080) INR in Blood by Coagulation assay

4193

33414

1.46

66.78

9.2

9.5

1.2

1.3

inr

2.69

1130

9337

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1444

9119

1.69

65.97

1.9

1.7

—

(3030467) Casts [#/volume] in Urine by Automated count

3026

22680

1.49

65.68

3.6

3.2

0.3

0.4

e6/l

4.80

2350

17098

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8862

82936

2.07

65.51

12.5

10.7

25.0

25.8

u/l

3.24

8584

79797

(3044290) Cell count panel - Cerebral spinal fluid

371

1454

2.61

62.66

1.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1427

9108

1.67

62.30

1.9

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

267

882

3.09

62.04

2.6

2.7

—

(3000850) Epithelial cells [#/volume] in Urine

2388

17286

1.51

60.38

2.8

2.6

5.0

5.6

e6/l

1.74

2111

15100

(3002582) Erythrocytes [#/volume] in Urine

3211

24683

1.46

59.87

3.7

3.3

65.2

90.5

e6/l

0.89

2506

18952

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1836

12583

1.57

59.54

1.3

10.4

13.2

u/ml

0.94

676

4760

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

188

512

3.73

59.29

1.1

1.0

281.6

291.1

mg/l

1.01

170

462

(3037522) Nuclear Ab [Titer] in Serum

1569

10401

1.61

58.53

1.4

1.3

555.4

527.4

titre

0.20

307

2252

(40768797) Stomach Pathology biopsy report

1654

11150

1.59

57.37

1.3

1.2

—

(3044889) 12 lead EKG panel

6351

55450

1.44

57.34

4.6

3.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3239

25120

1.44

56.83

3.2

30.8

35.3

u/l

3.83

3016

23749

(3048689) Calprotectin [Mass/mass] in Stool

1392

9027

1.64

56.62

2.0

2.2

141.6

139.1

ug/g

0.08

1076

7047

(3029937) Albumin [Presence] in Urine by Test strip

2788

21061

1.46

56.12

5.3

4.2

0.0

estimate

0.34

863

6986

(3007461) Platelets [#/volume] in Blood

9051

86054

2.17

53.20

28.9

22.2

247.7

249.8

e9/l

2.46

8896

83761

(3035941) MCH [Entitic mass]

9051

86087

2.16

52.60

28.7

22.1

30.4

30.3

1.04

8959

84788

(3024731) MCV [Entitic volume]

9051

86089

2.16

52.56

28.8

22.1

91.4

91.2

4.51

8958

84791

(3026361) Erythrocytes [#/volume] in Blood

9051

86097

2.16

52.42

28.9

22.2

4.4

4.5

e12/l

3.70

8859

83540

(3000963) Hemoglobin [Mass/volume] in Blood

9052

86113

2.16

52.37

29.1

22.3

133.7

134.3

g/l

3.85

8957

84827

(3010813) Leukocytes [#/volume] in Blood

9051

86116

2.15

52.07

28.9

22.2

6.8

e9/l

0.86

8868

83545

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8411

78302

1.66

51.57

5.6

5.0

2.7

mmol/l

8.94

7714

71626

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1960

14007

1.50

51.43

3.1

2.8

1.2

1.4

e6/l

0.35

1159

8037

(40761535) Cells panel - Urine sediment

1083

6748

1.68

51.11

4.2

3.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

212

705

3.05

48.73

1.1

83.4

74.0

au/ml

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5331

45826

1.37

47.91

3.0

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1493

10206

1.55

47.82

9.1

7.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7965

73471

1.53

47.81

16.9

14.2

78.8

78.6

ml/min/173m2

0.35

6704

60759

(3001186) Copper [Moles/volume] in Serum or Plasma

156

5.68

47.31

1.1

1.3

16.8

16.9

umol/l

0.08

142

(4010399)

940

5767

1.70

46.80

1.5

1.4

—

(40758558) Short blood count panel - Blood

2635

20244

1.42

46.52

6.5

6.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2162

16025

1.45

46.45

4.4

3.8

309.6

451.7

ng/l

0.80

1664

12806

(1001926) Buprenorphine [Presence] in Urine by Screen method

349

1547

2.30

45.04

2.5

2.1

—

(3011288) Drugs identified in Urine by Screen method

317

1348

2.40

44.99

3.3

2.8

—

(3003396) Base excess in Arterial blood by calculation

1378

9369

1.55

44.98

5.9

7.0

1.4

1.1

mmol/l

1.73

1110

7322

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1523

10605

1.52

44.49

5.2

5.8

1.0

mmol/l

0.46

1401

9830

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1378

9402

1.54

44.21

5.9

7.0

5.1

kpa

1.44

1319

8961

(3027801) Oxygen [Partial pressure] in Arterial blood

1377

9400

1.54

44.06

5.9

7.0

11.6

12.3

kpa

5.60

1311

8951

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3647

29794

1.36

43.80

5.0

4.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

929

5778

1.67

43.79

1.9

2.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2723

21224

1.40

43.64

2.7

2134.3

5016.7

umol/l

5.87

2295

18186

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

159

476

3.38

43.52

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

165

511

3.27

42.78

1.2

36.1

42.3

mg/l

1.03

139

431

(3020630) Protein [Mass/volume] in Serum or Plasma

1075

6980

1.61

42.65

2.0

2.6

66.9

66.3

g/l

1.91

967

6294

(3033658) Prothrombin time (PT) actual/Normal

2624

20436

1.39

41.90

4.1

4.0

89.3

89.0

0.20

2546

19936

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8209

76677

1.53

41.62

5.0

4.5

4.6

mmol/l

14.69

7556

70511

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

159

492

3.27

41.30

1.1

236.1

279.0

mg/l

1.95

139

427

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8152

76080

1.51

40.99

4.9

4.5

1.4

1.5

mmol/l

10.52

7445

69545

(3016879) Cocaine [Presence] in Urine

384

1843

2.13

40.75

2.5

2.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

808

4940

1.69

40.51

1.8

1.7

—

(3019060) Gas panel - Arterial blood

871

5443

1.66

40.17

4.2

4.8

—

(3016502) Oxygen saturation in Arterial blood

1239

8431

1.54

39.92

6.1

7.3

95.4

95.6

0.63

1193

8115

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

146

438

3.37

39.86

1.1

5.0

10.1

nmol/l

0.41

(3023410) Appearance of Cerebral spinal fluid

194

691

2.85

39.49

1.4

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

400

1983

2.06

38.95

2.5

2.1

—

(3009508) Creatinine [Moles/volume] in Urine

3138

25397

1.35

38.67

3.3

3.2

7.3

mmol/l

0.16

2600

21129

(36660697) Celiac disease serology panel - Serum

930

5978

1.62

38.25

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1724

12651

1.44

38.03

2.0

2.1

29.7

29.9

0.52

1672

12265

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

174

4.86

38.02

1.2

94.4

133.7

nmol/l

1.58

133

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

181

634

2.89

38.01

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7898

73482

1.45

37.99

4.4

4.0

1.3

mmol/l

4.76

7137

66620

(3027008) Opiates [Presence] in Urine

399

1995

2.04

37.96

2.5

1.9

—

(3028300) Cannabinoids [Presence] in Urine

400

2002

2.04

37.95

2.5

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

767

4723

1.68

37.34

1.6

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

771

4770

1.67

36.85

3.1

3.3

4.4

pmol/l

0.75

653

4191

(3027945) Reticulocytes/100 erythrocytes in Blood

1342

9438

1.49

36.74

2.4

2.5

1.7

1.8

0.92

1125

8322

(3023183) Ammonium ion [Moles/volume] in Plasma

336

1597

2.14

36.56

2.4

2.7

31.6

34.5

umol/l

1.42

283

1350

(3022217) INR in Platelet poor plasma by Coagulation assay

1544

11190

1.45

36.20

30.1

26.9

1.4

inr

0.20

165

1601

(3027944) Amphetamines [Presence] in Urine

389

1962

2.02

36.13

2.5

2.0

—

(1002224) Polysomnography panel

496

2723

1.87

35.86

1.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

925

6035

1.59

35.64

1.7

1.6

—

(4027681)

127

375

3.42

35.59

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

964

6357

1.57

35.47

3.5

3.8

88.5

91.6

ng/l

0.45

829

5416

(3000494) Fungus identified in Specimen by Culture

1306

9200

1.49

35.35

1.5

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1053

7098

1.54

35.13

5.9

6.7

1.4

1.3

mmol/l

0.01

1018

6841

(40760892) CBC W Ordered Manual Differential panel - Blood

2188

16964

1.38

34.69

4.4

4.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4374

37528

1.31

34.59

4.0

4.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1065

7242

1.53

34.08

2.6

2.4

5.2

7.0

ug/l

4.31

882

6262

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1125

7743

1.51

34.01

6.4

7.7

121.9

120.6

g/l

1.40

1089

7472

(3015171) Extractable nuclear Ab [Units/volume] in Serum

529

3015

1.80

33.86

1.3

1.0

u/ml

0.00

287

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

501

2812

1.83

33.73

2.0

2.3

277.4

674.7

ug/l

3.26

468

2643

(3016018) Differential panel - Cerebral spinal fluid

194

751

2.62

33.67

1.3

1.4

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

151

514

2.97

33.43

1.0

789.2

702.0

ng/l

1.21

100

349

(3026782) Osmolality of Urine

2089

16169

1.37

33.25

2.9

2.8

533.4

542.4

mosm/kgh2o

1.11

1751

13729

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

151

517

2.95

33.09

1.0

40.3

45.8

ng/l

0.59

102

355

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

150

512

2.96

33.05

1.0

277.2

340.4

ng/l

2.69

104

357

(3044640) Blood type and Crossmatch panel - Blood

3124

25758

1.32

32.38

2.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

799

5149

1.60

32.31

6.5

7.0

25.0

24.6

mmol/l

2.79

760

4805

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

802

5183

1.60

32.04

3.9

3.6

5.2

kpa

1.49

740

4784

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1720

13000

1.39

31.40

3.4

3.0

3.2

2.7

e6/l

1.07

927

7086

(3009343) pH of Capillary blood

791

5119

1.59

31.40

3.9

3.6

7.4

0.20

107

657

(3019225) pH of Specimen

1183

8362

1.47

31.20

4.7

4.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

572

3413

1.72

31.18

1.2

1.1

359.2

195.4

titre

0.47

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1084

7530

1.50

31.18

2.5

2.4

31.4

44.7

u/l

1.37

905

6428

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

764

4932

1.60

30.62

3.8

3.6

1.9

mmol/l

0.19

578

3669

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

405

2202

1.88

30.17

1.2

—

(3020891) Body temperature

548

3272

1.72

29.79

5.1

4.8

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

430

2402

1.83

29.39

1.4

280.7

271.4

ug/g

0.44

271

1416

(3014765) Yersinia sp identified in Stool by Organism specific culture

405

2222

1.86

29.32

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

406

2232

1.86

29.21

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

103

5.46

29.04

2.1

2.0

15.8

17.3

umol/l

0.39

103

(3000991) Gas panel - Venous blood

985

6837

1.49

28.30

7.2

8.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

436

2474

1.80

28.30

4.1

4.3

3.9

mmol/l

0.02

417

2320

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2422

19563

1.32

28.24

2.5

2.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

434

2461

1.80

28.23

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

1293

9473

1.42

27.94

1.9

1.8

—

(3033942) Copper [Moles/time] in 24 hour Urine

13.72

27.92

1.1

0.3

umol/24h

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

749

4922

1.57

27.74

1.3

1.2

108.4

141.7

iu/ml

1.51

281

1799

(3021589) Normoblasts [#/volume] in Blood

4022

34807

1.27

27.21

10.1

9.8

0.0

e9/l

0.31

3251

28391

(3005719) IgG [Mass/volume] in Serum or Plasma

854

5814

1.52

26.89

2.4

2.7

10.3

10.5

g/l

0.66

780

5321

(3018405) Lactate [Moles/volume] in Arterial blood

488

2908

1.71

26.70

4.0

1.4

mmol/l

0.37

483

2860

(3000492) Spirometry study

1004

7094

1.46

26.27

1.5

—

(3012516) Albumin [Mass/volume] in Urine

2894

24178

1.28

25.65

3.3

676.4

393.3

mg/l

1.66

1821

15088

(3005322) IgE [Units/volume] in Serum or Plasma

692

4548

1.56

25.56

1.3

139.6

224.9

u/ml

5.02

641

4189

(40768804) Tissue Pathology biopsy report

3777

32626

1.26

25.34

2.2

2.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

372

2088

1.81

25.04

1.9

1.7

280.8

309.4

mu/l

1.27

337

1894

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

519

3214

1.65

24.54

4.4

3.9

25.0

24.9

mmol/l

0.61

483

2931

(3022313) Gas panel - Capillary blood

581

3701

1.61

24.52

4.1

3.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

734

4935

1.53

24.44

2.7

2.1

12.4

12.3

nmol/l

0.19

639

4294

(3023520) Reticulocytes [#/volume] in Blood

997

7139

1.44

24.23

2.4

2.5

69.8

69.4

e9/l

0.13

750

5396

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1235

9195

1.39

24.06

2.6

2.7

6.4

8.6

umol/l

6.82

1024

7967

(3024869) Neuronal Ab [Presence] in Serum

143

4.29

23.83

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

320

1747

1.86

23.57

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

320

1747

1.86

23.57

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1476

11361

1.35

23.32

2.0

—

(4198724)

236

3.41

22.60

2.3

2.6

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1354

10330

1.36

22.60

6.5

6.8

104.2

104.4

mmol/l

0.80

1325

10110

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

402

2378

1.72

22.59

1.6

1.8

—

(3012544) pH of Venous blood

1069

7870

1.40

22.14

4.2

3.9

7.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

514

3261

1.61

22.04

1.8

1.9

39.0

39.2

u/l

0.10

459

2840

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1549

12103

1.33

22.02

1.6

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

102

355

2.89

21.85

1.1

1.0

1.1

u/l

0.91

173

(3002032) Base excess in Venous blood by calculation

1032

7575

1.41

21.73

4.3

3.9

2.0

1.9

mmol/l

0.32

867

6159

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1035

7602

1.41

21.71

4.3

3.9

5.9

5.8

kpa

1.78

1001

7383

(3013139) Helicobacter pylori Ag [Presence] in Stool

753

5235

1.48

21.25

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

7433

70042

1.28

21.14

20.9

16.2

39.7

39.4

2.53

4906

48475

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

584

3881

1.54

20.47

4.2

24.5

24.2

mmol/l

1.41

513

3487

(3004716) Salmonella sp identified in Stool by Organism specific culture

541

3543

1.56

20.25

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

209

3.42

20.17

3.2

2.3

136.4

146.6

nmol/l

0.37

179

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

453

2851

1.62

20.08

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

6846

64022

1.25

19.90

22.6

18.3

13.7

13.8

0.93

6730

62653

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

479

3067

1.59

19.77

2.1

2.3

2.9

3.1

g/l

2.73

376

2367

(3020779) Urea [Moles/volume] in Serum or Plasma

989

7319

1.39

19.76

6.4

7.2

9.7

10.2

mmol/l

1.29

928

6970

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

563

3742

1.54

19.72

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

116

459

2.55

19.44

1.4

1.5

5.2

6.2

u/l

1.43

388

(3022145) Colonoscopy Study observation

1169

8911

1.36

19.41

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2966

25483

1.24

19.34

4.1

4.0

8.6

9.4

mg/mmol

0.42

1837

15854

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

302

1726

1.77

19.19

2.0

1.7

41.9

42.8

nmol/l

0.27

290

1658

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

252

3.11

19.08

1.7

2.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1230

9472

1.34

19.08

3.3

4.1

237.8

244.8

u/l

0.90

1128

8908

(3013512) EKG study

2796

23906

1.24

18.98

4.5

4.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

652

4519

1.48

18.65

2.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

472

3065

1.57

18.35

2.2

2.3

10.0

10.3

g/l

0.87

389

2561

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

467

3032

1.57

18.17

1.1

2.5

1.5

u/ml

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

130

561

2.34

18.07

1.2

1.3

1.9

2.1

mmol/l

1.07

125

524

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

121

4.07

17.95

1.1

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

391

2441

1.63

17.93

2.3

2.2

0.0

g/l

1.52

358

2214

(3025941) Bacteria identified in Stool by Culture

622

4307

1.48

17.87

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

498

3298

1.54

17.73

2.1

2.3

7.1

7.5

g/l

3.96

380

2427

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

230

1240

1.88

17.71

2.2

1.9

178.2

198.6

pmol/l

1.87

219

1159

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

328

1964

1.69

17.68

1.1

3.6

8.7

u/ml

1.58

212

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

497

3292

1.54

17.68

2.1

2.3

3.7

3.8

g/l

0.96

368

2317

(3023323) Follitropin [Units/volume] in Serum or Plasma

439

2830

1.58

17.62

1.4

1.3

27.3

30.6

iu/l

1.24

376

2430

(3024354) Oxygen [Partial pressure] in Venous blood

850

6253

1.39

17.53

3.6

3.3

4.6

4.5

kpa

0.45

816

6048

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

356

2184

1.65

17.50

1.3

36.5

42.2

u/ml

0.15

128

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

496

3295

1.53

17.41

2.1

2.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

379

2369

1.62

17.30

1.7

1.6

1.2

g/l

0.26

359

2232

(4034850)

397

2514

1.60

17.19

11.5

10.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

190

971

1.98

17.17

1.5

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

430

2776

1.58

17.15

2.3

0.6

0.9

g/l

1.10

375

2369

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2810

24247

1.23

17.09

5.3

5.2

2.5

3.5

ug/l

2.33

2486

21643

(3003338) MCHC [Mass/volume]

6897

64905

1.23

17.07

26.0

19.5

331.6

331.9

g/l

1.49

6852

64408

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

360

2231

1.64

17.02

2.4

2.3

0.0

g/l

0.00

331

2045

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

399

2543

1.59

16.82

2.3

2.2

38.7

37.4

g/l

4.10

342

2165

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

392

2489

1.60

16.79

1.7

3.3

3.7

mg/l

0.38

325

1765

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

368

2302

1.62

16.76

1.7

1.6

0.2

g/l

1.51

344

2171

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

364

2272

1.63

16.72

2.3

0.0

g/l

0.50

333

2053

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

964

7299

1.36

16.60

3.0

2.9

190.7

206.1

ng/l

0.63

884

6660

(46235355) HIV 1 and 2 tests - Meaningful Use set

1430

11464

1.29

16.43

1.9

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

306

2.73

16.09

1.3

1.7

29.8

29.7

umol/l

0.02

296

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

270

1575

1.74

16.04

1.2

43.9

39.1

u/ml

0.18

164

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

147

706

2.10

15.79

1.3

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

228

1283

1.80

15.35

1.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

510

3500

1.48

15.33

1.2

1.6

22.4

14.1

u/ml

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

287

1726

1.68

15.27

1.4

1.3

10.5

11.3

u/l

0.38

231

1392

(3052851) Hemolysis interference index of Serum or Plasma

389

2524

1.56

15.21

3.5

3.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

412

2.42

15.01

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

324

2024

1.62

14.87

1.3

6.6

7.1

u/ml

0.09

313

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

386

2.45

14.68

1.1

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

983

7612

1.33

14.48

2.2

0.2

g/l

4.09

915

7071

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2263

19368

1.22

14.44

4.7

4.5

22.0

0.04

1078

9785

(3017732) Neutrophils [#/volume] in Blood

734

5440

1.38

14.42

2.9

3.0

4.0

4.1

e9/l

0.74

531

4126

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

549

3889

1.44

14.00

1.6

1.7

1.5

1.6

g/l

0.54

461

3323

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

317

2000

1.61

13.99

1.3

13.4

4.6

u/ml

0.47

206

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

147

740

2.00

13.95

1.6

—

(3049717) Cytology report of Urine Cyto stain

461

3170

1.48

13.74

2.5

2.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

597

4308

1.41

13.74

7.3

8.9

24.5

24.3

mmol/l

0.80

545

4020

(3035637) Corticotropin [Mass/volume] in Plasma

178

967

1.86

13.49

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

487

3415

1.45

13.13

2.0

1.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

528

3759

1.43

13.11

3.4

2.8

0.7

0.58

505

3604

(3028026) IgM [Mass/volume] in Serum or Plasma

622

4562

1.39

13.02

1.8

1.9

1.4

g/l

0.11

559

4139

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

297

1886

1.59

12.79

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1242

10087

1.27

12.62

5.1

4.6

33.1

32.8

0.32

856

6747

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

196

1120

1.77

12.61

1.3

0.4

0.2

nmol/l

0.56

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

195

1115

1.76

12.52

1.3

0.6

2.0

nmol/l

0.72

188

1071

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

395

2684

1.49

12.52

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

410

2816

1.48

12.32

2.6

2.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

180

1014

1.79

12.17

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2393

20873

1.20

12.15

1.7

1.6

1.4

mmol/l

0.44

2021

17376

(3020191) Ethanol [Moles/volume] in Serum or Plasma

113

547

2.08

12.00

1.5

1.4

1.2

1.3

promille

0.09

414

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

104

488

2.14

11.98

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

297

1919

1.57

11.90

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

284

1824

1.57

11.69

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

452

3197

1.43

11.66

2.0

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

827

6441

1.31

11.63

2.6

63.9

64.1

ml/min/173m2

0.06

343

2584

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

361

2448

1.49

11.58

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

484

3478

1.41

11.43

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

394

2737

1.46

11.20

1.5

1.6

150.4

285.4

titre

1.14

123

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

223

2.66

11.03

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

101

486

2.09

10.94

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

372

2.24

10.75

1.6

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

260

1670

1.57

10.73

1.2

2.4

4.1

u/ml

0.45

121

(3042517) Benzodiazepines panel - Urine

4.72

10.69

3.0

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1031

8347

1.26

10.68

1.6

1.7

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

641

4878

1.34

10.61

6.6

7.0

25.1

24.8

mmol/l

1.42

632

4843

(3047181) Lactate [Moles/volume] in Blood

368

2550

1.46

10.61

4.9

6.1

1.3

mmol/l

0.03

329

2255

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

263

2.48

10.60

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

183

1084

1.70

10.44

2.1

2.2

17.2

25.1

mg/l

1.90

279

(3014271) Vancomycin [Susceptibility]

427

2.12

10.15

3.1

2.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

402

2.15

10.07

1.2

210.4

279.3

u/l

0.74

369

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

295

2.35

10.00

1.1

2543.9

429.5

ng/l

0.42

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

708

5527

1.30

9.78

2.3

1.9

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

980

7973

1.26

9.72

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

777

6160

1.28

9.54

2.4

2.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

2.62

9.54

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

200

2.61

9.45

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

380

2.14

9.43

2.6

2.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

201

2.60

9.36

1.0

1.1

—

(4094501)

303

2078

1.47

9.26

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

3.81

9.20

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

290

1978

1.48

9.12

1.4

—

(3024928) Oxygen saturation in Venous blood

254

1687

1.52

9.09

3.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

278

2.31

8.99

1.3

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

304

2099

1.46

8.99

2.8

3.1

25.2

24.9

mmol/l

0.58

265

1826

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

199

1260

1.59

8.81

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

135

773

1.76

8.77

1.1

—

(21494755) Public health laboratory ask at order entry panel

434

5799

0.74

8.72

1.4

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

185

2.60

8.72

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

321

2255

1.44

8.68

1.4

22.7

15.4

iu/ml

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

635

4971

1.30

8.61

3.6

3.4

128.8

128.3

g/l

0.20

624

4851

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

204

2.51

8.59

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

250

1681

1.50

8.46

1.3

1.2

7.0

12.5

u/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

275

1897

1.46

8.21

2.0

2.2

130.9

128.2

g/l

0.99

201

1360

(3039162) Centromere protein B Ab [Units/volume] in Serum

158

964

1.65

8.16

1.2

1.3

39.6

59.3

u/ml

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.35

8.13

1.0

—

(4024509)

140

831

1.69

8.04

1.7

1.6

—

(3037121) Protein [Mass/volume] in Urine

383

2823

1.37

7.87

2.9

3.0

0.3

g/l

0.52

135

1144

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

170

1067

1.60

7.86

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

514

1.88

7.81

1.2

1.3

0.9

1.3

u/ml

0.29

246

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.30

7.77

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

132

779

1.70

7.76

3.7

3.5

—

(3036489) Thrombin time

389

2886

1.36

7.68

1.7

2.1

21.4

21.5

0.16

346

2532

(3045683) HLA typing for celiac disease panel - Blood or Tissue

386

2.00

7.61

1.1

1.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

6.67

7.60

1.5

1.7

135.3

230.0

nmol/l

—

(3008898) HLA-B27 [Presence]

319

2296

1.40

7.58

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2298

20622

1.15

7.58

4.1

3.5

—

(3045414) Leukocytes [Presence] in Urine

479

3677

1.32

7.53

2.0

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

649

5185

1.27

7.51

1.7

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.30

7.50

1.0

—

(3003577) Lead [Moles/volume] in Blood

4.60

7.39

1.1

1.3

0.1

umol/l

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

165

1049

1.58

7.26

1.5

1.4

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.14

7.26

1.1

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

164

1042

1.58

7.24

1.5

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

222

2.30

7.21

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

190

1251

1.53

7.17

1.5

0.6

0.8

g/l

1.35

149

945

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1582

13868

1.17

7.09

3.3

3.1

0.7

0.8

ug/l

0.94

1107

9524

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

173

1122

1.55

7.00

1.1

63113.8

817.4

iu/ml

0.48

263

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.85

6.97

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

130

2.70

6.90

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

6.01

6.90

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

269

1914

1.42

6.87

1.8

82.1

4.5

iu/l

0.80

674

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

319

2.04

6.85

3.6

2.0

150.0

125.2

umol/l

0.25

174

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

290

2094

1.40

6.81

1.9

2.0

10.9

11.8

mg/l

1.09

268

1926

(3023419) Bacteria identified in Sputum by Culture

157

1003

1.57

6.80

2.9

2.5

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.10

6.80

1.0

1.7

42.3

38.7

0.10

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

561

4461

1.27

6.77

7.9

9.4

—

(3044927) Protein electrophoresis panel - Urine

140

874

1.61

6.69

1.1

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

437

3372

1.31

6.66

2.0

1.9

1.6

2.3

ug/l

0.76

368

2953

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

192

1289

1.50

6.65

1.6

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

161

1042

1.55

6.60

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

394

1.91

6.54

1.4

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

148

942

1.58

6.53

1.1

2.0

3.4

u/ml

1.41

406

(3010421) pH of Blood

294

2145

1.38

6.50

4.1

7.4

0.10

247

1807

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

190

1284

1.49

6.39

1.4

114.7

118.9

u/ml

0.19

264

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

160

1043

1.54

6.37

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

286

2085

1.38

6.37

1.2

101.0

150.8

titre

0.57

180

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

4.05

6.34

3.4

9.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

501

3962

1.28

6.34

4.0

3.5

25.3

25.2

mmol/l

0.27

487

3846

(3028626) Oxygen [Partial pressure] in Capillary blood

261

1876

1.40

6.32

3.5

3.1

8.3

8.1

kpa

1.08

246

1732

(3005988) Vibrio sp identified in Specimen by Organism specific culture

160

1046

1.54

6.30

1.5

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

125

2.65

6.29

1.3

1.5

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

4.22

6.27

1.0

1.8

7.3

17.1

1.23

(3040151) Glucose [Moles/volume] in Capillary blood

148

953

1.56

6.23

11.8

13.1

7.6

7.3

mmol/l

0.41

121

789

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

390

1.88

6.08

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1141

9861

1.18

6.06

1.6

—

(3012501) Base excess in Blood by calculation

255

1840

1.40

6.06

4.1

4.2

2.7

2.6

mmol/l

0.34

176

1254

(3013290) Carbon dioxide [Partial pressure] in Blood

255

1842

1.39

6.02

4.1

4.2

5.1

5.0

kpa

2.34

247

1807

(3003181) Sodium [Moles/volume] in Urine

212

1485

1.44

5.96

1.3

1.4

64.5

63.1

mmol/l

0.19

172

1181

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

299

2221

1.36

5.95

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

256

1856

1.39

5.92

4.1

4.2

8.8

8.5

kpa

1.54

248

1821

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

823

6926

1.21

5.91

3.9

1.2

mmol/l

0.77

688

6034

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

182

1241

1.48

5.89

1.2

1.1

1.4

u/ml

0.02

490

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

272

1994

1.37

5.88

2.5

2.2

5096.9

4767.3

u/l

0.06

799

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

468

3707

1.28

5.87

4.0

4.1

51.8

48.0

2.84

463

3663

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

446

1.80

5.84

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

272

1999

1.37

5.80

1.6

11605.8

13250.8

e6/l

0.33

199

1422

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

154

1022

1.52

5.70

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

359

2761

1.31

5.66

2.5

3.3

33.3

49.9

mg/l

2.18

294

2250

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

104

2.70

5.58

1.2

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

124

789

1.58

5.55

1.5

1.3

6.2

6.7

g/l

1.13

549

(3024139) IgG subclass 3 [Mass/volume] in Serum

124

789

1.58

5.55

1.5

1.3

0.4

g/l

0.80

550

(3047007) Chlamydophila sp Ab [Presence] in Serum

150

997

1.51

5.52

1.3

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

124

790

1.58

5.52

1.5

1.3

2.8

g/l

0.02

551

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

349

2686

1.31

5.48

2.5

3.3

2.2

2.8

ratio

0.18

213

(3011985) Renin [Units/volume] in Plasma

159

1072

1.49

5.47

1.4

69.5

58.5

mu/l

0.32

144

957

(1761482) Bacteria [#/volume] in Urine by Culture

151

2222

0.67

5.46

5.2

4.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

257

2.03

5.46

2.7

2.8

25.5

28.8

umol/l

0.99

194

(3008116) Ketones [Moles/volume] in Urine by Test strip

153

2.36

5.46

1.4

—

(40761536) Microorganisms panel - Urine sediment

797

6741

1.20

5.43

4.7

4.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

357

2761

1.30

5.42

2.5

3.3

56.1

76.2

mg/l

0.39

292

2249

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

307

1.93

5.36

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

203

1441

1.42

5.35

1.5

1.4

—

(4146454)

136

898

1.52

5.19

2.6

2.7

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

283

1.95

5.18

1.4

1.5

14.3

16.1

pmol/l

1.38

236

(4062490)

122

787

1.56

5.18

1.5

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

149

1006

1.49

5.12

1.3

296.3

304.6

pmol/l

0.07

115

761

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

356

1.83

5.08

1.6

1.7

6.6

5.0

nmol/l

0.19

291

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

185

1306

1.42

5.05

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

446

1.73

5.00

2.4

2.3

13.2

24.0

umol/l

—

(3021901) Oxygen saturation in Capillary blood

210

1520

1.39

4.97

2.7

2.9

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

117

755

1.56

4.97

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

811

1.54

4.96

2.8

3.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

166

1154

1.45

4.93

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

141

951

1.49

4.89

1.3

29.4

29.5

u/l

0.01

105

771

(3051651) Icteric interference index of Serum or Plasma

487

1.69

4.87

3.3

3.4

—

(3008295) Osmolality of Serum or Plasma

126

831

1.52

4.86

1.5

1.4

284.6

277.8

mosm/kgh2o

2.40

638

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.78

4.86

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

973

8452

1.17

4.86

3.9

3.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

120

787

1.53

4.76

1.6

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

366

2892

1.28

4.75

2.7

3.0

0.4

0.3

u/ml

0.21

210

1645

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

446

1.71

4.73

1.1

14.0

10.0

iu/ml

0.16

116

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

260

1964

1.33

4.72

1.5

1.7

—

(3039000) Anion gap in Blood

245

1837

1.34

4.68

5.7

6.9

11.1

11.2

mmol/l

0.30

218

1653

(3018572) Chloride [Moles/volume] in Blood

245

1838

1.34

4.66

5.7

6.9

105.0

mmol/l

0.02

218

1654

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

183

1311

1.40

4.63

1.2

1.3

42.9

38.6

u/l

0.11

155

1141

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

4.14

4.62

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

324

1.83

4.61

2.5

2.2

52.9

54.9

umol/l

0.25

262

(3038177) Helicobacter pylori Ab [Presence] in Serum

168

1187

1.42

4.60

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

479

5803

0.82

4.47

1.8

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

802

6908

1.18

4.46

3.7

4.1

1.0

0.9

0.10

214

2011

(3023420) DNA double strand Ab [Units/volume] in Serum

123

824

1.50

4.45

1.5

1.4

29.9

22.3

iu/ml

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

4.00

4.43

1.0

1.6

5.9

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

322

1.81

4.39

1.3

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

182

1316

1.39

4.39

1.2

322.4

279.1

u/ml

0.67

114

815

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

272

2094

1.31

4.35

1.5

—

(1616796) Gas panel - Central venous blood

241

1825

1.33

4.33

3.8

3.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

257

1966

1.32

4.30

2.2

2.3

76.8

96.7

ug/min

0.55

143

1147

(3025159) Blasts/100 leukocytes in Blood

719

6161

1.18

4.27

3.7

4.1

0.1

0.3

1.21

171

1558

(3034770) Mitochondria Ab [Titer] in Serum

271

2095

1.30

4.21

1.1

1.2

681.7

890.7

titre

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

129

884

1.47

4.20

1.2

60.3

64.5

u/l

0.34

590

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

417

1.68

4.17

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

417

1.68

4.17

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

144

1009

1.43

4.17

1.1

1.5

g/l

1.37

129

909

(3021440) Promyelocytes/100 leukocytes in Blood

760

6557

1.17

4.16

3.7

4.1

0.2

0.1

0.48

196

1859

(3020717) Zinc [Moles/volume] in Serum or Plasma

380

1.72

4.15

1.2

1.5

24.7

23.6

umol/l

0.10

360

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

418

1.68

4.14

1.6

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

160

2.13

4.14

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

128

879

1.46

4.13

3.6

3.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.53

4.12

2.1

2.0

—

(3045424) Erythrocytes [Presence] in Urine

187

1374

1.37

4.12

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

274

2131

1.29

4.08

1.4

1.3

—

(3019230) Fractional oxyhemoglobin in Venous blood

188

1385

1.36

4.08

3.5

2.9

64.1

63.5

0.13

188

1380

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

148

2.17

4.07

1.1

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

179

1309

1.37

4.06

1.9

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

141

990

1.43

4.05

1.3

—

(44813793)

498

1.61

4.04

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

609

5177

1.19

3.98

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

2.04

3.93

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

154

1107

1.40

3.89

1.1

6.6

5.0

u/ml

0.43

551

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

560

1.56

3.84

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

560

1.56

3.84

1.1

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

107

2.34

3.82

1.0

1.3

45.8

53.3

0.29

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

569

1.55

3.81

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

563

1.55

3.75

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

166

1217

1.37

3.74

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

139

989

1.41

3.74

1.1

2.2

2.0

u/ml

0.05

223

(3023430) Cat dander IgE Ab [Units/volume] in Serum

114

782

1.46

3.74

1.1

6.2

3.6

u/ml

0.50

302

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

423

1.64

3.73

1.1

18.0

30.4

u/l

1.88

320

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

564

1.55

3.73

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

129

907

1.43

3.71

1.4

0.3

0.4

nmol/l

1.95

103

684

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.00

3.69

1.4

524.9

440.6

nmol/l

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

425

1.63

3.67

1.1

71.0

89.3

u/l

2.06

330

(3022621) pH of Urine by Test strip

631

5421

1.18

3.67

3.7

3.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

192

1445

1.34

3.66

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

559

1.54

3.65

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

188

1412

1.34

3.64

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

265

2086

1.28

3.64

2.2

3.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

102

692

1.48

3.55

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

102

692

1.48

3.55

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

102

692

1.48

3.55

1.5

1.6

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

563

1.53

3.55

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.57

3.54

1.2

1.7

1.6

umol/24h

0.11

(3010144) Erythrocytes [#/volume] in Synovial fluid

111

767

1.45

3.53

1.3

1.4

146523.2

146092.5

e6/l

0.00

523

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

588

1.52

3.52

1.3

11.6

12.2

mmol/l

0.23

160

(3021788) Differential panel - Synovial fluid

197

1498

1.32

3.52

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.81

3.51

1.0

1.2

8.6

15.1

u/l

0.69

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

166

1232

1.35

3.49

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

208

1.88

3.42

1.7

1.5

0.5

0.4

ug/l

0.61

127

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

584

1.51

3.42

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1290

11702

1.12

3.39

1.5

1.4

—

(1761868) Lipid panel - Serum or Plasma

2413

25737

0.92

3.39

3.0

2.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

514

1.54

3.37

2.7

2.4

491.3

515.3

e6/l

0.19

429

(3032057) Clostridioides difficile [Presence] in Stool

183

1.92

3.27

1.8

1.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

145

1066

1.37

3.27

1.1

1.0

1.1

u/ml

0.08

445

(21494890) Protein electrophoresis panel - 24 hour Urine

122

872

1.40

3.25

1.6

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

289

2334

1.25

3.24

1.7

2.2

92.3

91.0

0.44

270

2189

(3002179) Metamyelocytes/100 leukocytes in Blood

717

6285

1.15

3.24

3.5

3.9

0.6

0.17

145

1438

(3007463) Buprenorphine [Presence] in Urine

4.74

3.23

3.2

7.3

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

576

1.50

3.23

3.1

3.5

126.1

133.6

nmol/l

0.09

570

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

243

1926

1.27

3.20

1.5

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

227

1788

1.28

3.16

3.7

3.1

0.9

0.8

nmol/l

0.42

182

1359

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

268

2155

1.25

3.13

2.0

2.5

185.8

196.4

1.09

253

2050

(3027923) C peptide [Moles/volume] in Serum or Plasma

412

1.58

3.13

1.5

1.3

1.0

1.2

nmol/l

0.67

312

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.96

3.13

1.2

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

197

1526

1.30

3.12

2.9

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

118

846

1.40

3.11

1.1

4.8

3.4

u/ml

0.27

321

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

252

1.75

3.11

1.2

0.3

g/l

0.45

201

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

144

1068

1.35

3.09

5.2

6.3

12.1

11.9

mg/l

0.20

128

986

(40768443) Skin Pathology biopsy report

437

3698

1.19

3.08

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

281

2279

1.24

3.05

2.0

2.5

3.5

3.6

g/l

0.31

264

2157

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

113

2.13

2.99

1.2

219.9

115.2

ng/l

0.44

(3035320) C reactive protein [Mass/volume] in Body fluid

583

1.46

2.88

4.3

2.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.25

2.86

3.3

2.6

0.6

0.5

u/field

0.18

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

116

843

1.38

2.86

1.6

—

(3044941) Cell count panel - Synovial fluid

165

1266

1.31

2.84

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

164

1.89

2.84

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

496

1.50

2.81

2.7

2.5

0.2

e9/l

0.59

428

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

440

1.53

2.80

1.4

64.9

129.5

pmol/l

0.47

138

(3048929) Epstein Barr virus Ab [Presence] in Serum

252

2042

1.24

2.79

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

156

1191

1.32

2.79

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

202

1596

1.27

2.78

1.5

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.20

2.73

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

142

1074

1.33

2.72

1.3

1.2

4.3

u/ml

0.01

468

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

218

1.75

2.71

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

323

3855

0.83

2.70

1.5

1.4

—

(3037756) Immunofixation for Serum or Plasma

225

1808

1.25

2.70

1.4

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

211

1.76

2.69

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

407

1.53

2.62

9.3

11.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

529

1.46

2.62

1.5

1.6

6.3

6.6

u/l

0.05

251

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.66

2.62

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.55

2.61

3.0

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

494

4289

1.16

2.60

3.2

2.8

0.3

e6/l

0.05

480

4184

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.25

2.60

2.3

1.6

36.8

44.4

umol/l

0.84

(3008757) Leukocyte morphology finding [Identifier] in Blood

121

903

1.34

2.56

2.7

4.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

657

1.40

2.55

1.2

38.7

38.3

u/ml

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.42

2.53

1.3

1.2

1.5

1.0

ml/s/173m2

—

(3002256) Pathology report gross observation

1157

10604

1.10

2.53

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

229

1863

1.23

2.49

1.5

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

225

1.69

2.45

1.2

1.1

91.0

86.9

0.26

105

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

334

1.56

2.44

1.1

2.2

5.3

u/ml

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

120

902

1.33

2.44

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

176

1394

1.27

2.43

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

706

1.38

2.42

4.2

5.0

161.9

63.1

u/ml

0.65

203

(3000060) B lymphocytes [#/volume] in Blood

181

1.77

2.42

2.8

2.0

240.0

928.8

e6/l

0.83

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

110

2.00

2.40

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

313

1.57

2.37

1.1

0.5

1.9

u/ml

—

(3001019) Free T4 and TSH panel - Serum or Plasma

384

3298

1.17

2.35

1.8

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

233

1912

1.22

2.35

2.4

2.2

—

(44806118)

116

874

1.33

2.34

1.3

1.4

—

(44790047)

116

874

1.33

2.34

1.3

1.4

—

(44790048)

116

874

1.33

2.34

1.3

1.4

—

(44790049)

116

874

1.33

2.34

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.26

2.33

1.2

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.09

2.32

1.6

1.4

0.3

0.2

nmol/l

0.29

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.04

2.31

4.6

5.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.18

2.30

1.6

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

620

1.39

2.29

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

141

1096

1.29

2.28

1.3

1.2

1.9

3.7

u/ml

2.40

361

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.48

2.26

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.02

2.25

1.2

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

699

1.36

2.25

1.1

1.0

0.1

0.3

u/ml

1.81

159

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

149

1.81

2.23

1.2

67.1

77.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

217

1.66

2.21

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

736

1.35

2.20

1.7

2.0

10.1

7.9

umol/l

0.46

535

(3020491) Glucose [Moles/volume] in Blood

566

1.40

2.20

2.2

2.0

6.7

6.8

mmol/l

0.09

387

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.78

2.20

8.3

4.4

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.41

2.19

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

150

1.80

2.19

1.1

1.2

89.1

80.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

376

1.49

2.19

1.1

14.7

2.1

u/ml

0.41

114

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

141

1103

1.28

2.18

1.4

1.5

—

(3011412) CD3 cells [#/volume] in Blood

100

746

1.34

2.18

2.7

2.3

1.1

e9/l

0.00

444

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

185

1498

1.24

2.15

2.0

1.7

0.8

nmol/l

0.05

142

1254

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

1097

1.28

2.15

1.4

—

(3019977) pH of Arterial blood

477

1.43

2.14

2.3

2.7

7.4

0.93

169

(3028433) Virus identified in Specimen by Culture

274

1.57

2.13

1.3

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

154

1224

1.26

2.11

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

104

786

1.33

2.09

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

606

1.37

2.08

1.4

1.5

11.9

12.8

u/l

0.69

579

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

221

1.63

2.08

1.2

84.8

87.0

0.12

108

(3004451) EKG impression Narrative

406

1.46

2.06

1.4

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

161

1.74

2.05

1.1

1.2

0.5

104.3

mg/l

1.26

117

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

103

781

1.32

2.03

1.6

1.7

—

(3016038) Potassium [Moles/volume] in Urine

558

1.38

2.03

1.2

30.7

34.7

mmol/l

0.94

474

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

400

1.45

2.01

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

394

3439

1.15

2.00

4.5

5.0

1.7

1.6

0.61

363

3231

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

509

1.40

2.00

1.3

1.2

69.1

85.3

u/l

1.08

439

(3012565) Volume of 24 hour Urine

409

1.45

1.99

2.1

2.3

2098.0

1880.7

0.69

358

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

577

1.37

1.99

2.3

2.0

14.8

14.1

0.17

248

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.33

1.96

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.35

1.94

1.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

354

1.47

1.94

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

322

1.49

1.92

2.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

298

1.51

1.91

1.1

1724.8

1549.7

miu/ml

0.43

298

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

548

1.37

1.90

1.4

1.3

102.0

63.5

titre

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

1.89

1.90

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

364

1.46

1.89

1.0

1.1

5.2

1.1

u/ml

0.43

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

291

1.51

1.89

1.9

2.0

53.5

58.9

ug/l

0.31

282

(3033923) Metanephrine [Moles/time] in 24 hour Urine

173

1.68

1.89

1.1

0.8

0.6

umol/24h

0.70

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

515

1.38

1.88

2.6

2.5

926.1

680.9

e6/l

1.60

227

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.18

1.88

1.0

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

164

1334

1.23

1.87

2.2

1.9

1.6

1.7

mmol/l

0.37

158

1306

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

349

1.46

1.86

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

349

1.46

1.86

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

214

1790

1.20

1.85

2.9

2.5

16.9

16.1

2.01

124

935

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

100

1.90

1.85

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.21

1.84

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

268

2290

1.18

1.83

2.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

114

892

1.28

1.82

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

4.17

1.82

1.2

5.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

230

1.57

1.81

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

133

1062

1.26

1.80

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

191

1.63

1.80

1.0

1.2

848.1

290.3

pmol/l

0.41

137

(3052592) Norovirus Ag [Presence] in Stool

168

1.67

1.79

1.2

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

495

1.38

1.78

1.3

1.2

16.3

23.2

u/l

1.20

414

(3003129) Base excess in Capillary blood by calculation

223

1.57

1.78

1.5

1.8

0.8

0.7

mmol/l

0.07

205

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.17

1.77

1.7

1.3

21.8

21.9

mmol/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

192

1.62

1.77

1.0

1.1

1.6

6.6

u/ml

0.52

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.93

1.74

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

386

3408

1.14

1.71

4.6

5.1

0.9

0.61

355

3204

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

103

1.85

1.71

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

568

1.34

1.70

1.4

1.3

272.9

300.4

titre

—

(3005033) Fetal Nuchal fold Thickness US

971

0.75

1.69

1.3

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

104

1.83

1.66

1.1

1.0

111.9

77.6

ug/l

1.76

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

180

1.61

1.66

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

126

1012

1.25

1.65

1.4

1.6

53.5

59.1

0.77

640

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

144

1174

1.23

1.65

2.8

2.5

143.5

1864.1

u/ml

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.03

1.64

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

343

1.43

1.63

1.2

1.1

11.0

21.8

u/ml

—

(3006270) Folate [Moles/volume] in Blood

730

1.29

1.63

1.1

1.2

319.1

344.7

nmol/l

0.66

602

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

643

5866

1.10

1.62

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.57

1.61

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

974

0.76

1.60

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

403

1.39

1.60

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

403

1.39

1.60

1.4

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1007

0.76

1.60

1.4

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

127

1028

1.24

1.57

1.1

120.1

117.3

0.39

121

916

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

544

1.33

1.53

2.6

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

211

1799

1.18

1.53

1.6

1.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

519

1.33

1.52

1.2

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

169

1.60

1.51

2.8

2.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

721

1.28

1.51

1.9

1.0

g/24h

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.86

1.50

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

634

1.30

1.49

1.1

1.2

93.8

179.2

titre

1.54

114

(4281824)

928

0.76

1.49

1.3

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.07

1.49

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

384

1.38

1.48

1.3

1.5

1.4

4.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1184

0.79

1.47

1.3

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

1080

0.79

1.44

2.7

2.3

106.2

105.6

mmol/l

0.73

1068

(3041354) Potassium [Moles/volume] in Venous blood

1080

0.79

1.44

2.7

2.3

4.0

4.1

mmol/l

0.49

1068

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1180

0.79

1.44

1.3

1.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

166

1397

1.19

1.42

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

693

1.27

1.41

1.5

1.3

1.4

1.5

nmol/l

0.24

619

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.85

1.39

2.5

1.8

0.3

1.1

mmol/l

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.18

1.39

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1185

0.80

1.38

1.3

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.89

1.38

1.1

2.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.77

1.38

5.1

5.7

49.3

47.4

ug/min

0.04

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1184

0.80

1.38

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

424

1.35

1.37

2.2

1.9

2.0

2.8

u/field

0.50

288

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.80

1.37

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

391

1.36

1.35

2.8

3.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.87

1.34

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.13

1.33

1.4

1.6

419.2

323.9

umol/24h

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

128

1.64

1.32

1.1

1.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.78

1.32

1.1

24.4

4.1

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

241

1.45

1.31

1.2

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

130

1079

1.21

1.31

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.74

1.30

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

318

0.63

1.28

1.5

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

614

1.27

1.28

1.9

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.08

1.27

1.2

1.1

—

(4035726)

686

7392

0.92

1.27

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1059

0.80

1.25

1.4

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1059

0.80

1.25

2.7

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

105

1277

0.82

1.24

1.3

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

253

1.42

1.23

1.7

2.8

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

253

1.42

1.23

1.7

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

195

2246

0.87

1.22

1.3

1.5

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.63

1.21

5.0

8.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

639

0.75

1.20

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

172

1.51

1.20

2.1

1.6

132.6

127.1

ng/l

0.05

172

(3011648) Oxygen content in Venous blood

629

1.26

1.20

2.1

2.6

11.0

10.9

0.02

629

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

145

0.48

1.19

4.4

3.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

419

1.31

1.17

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

419

1.31

1.17

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

419

1.31

1.17

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

419

1.31

1.17

1.8

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

125

1050

1.19

1.15

1.9

2.1

32.4

32.7

0.26

125

1040

(3041918) Cholesterol [Moles/volume] in Pleural fluid

158

1.52

1.14

1.3

1.2

2.2

1.7

mmol/l

0.35

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

264

2349

1.13

1.6

0.4

6.4

iu/ml

1.17

528

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

634

1.25

1.13

1.0

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.85

1.13

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

415

1.30

1.10

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.95

1.08

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

128

1.56

1.08

1.2

1.4

—

(4268621)

739

1.22

1.06

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

420

0.71

1.06

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

649

1.23

1.06

1.6

24.9

23.6

u/ml

0.07

137

(3006922) Hepatitis E virus Ab [Presence] in Serum

506

1.27

1.06

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

105

1.62

1.05

1.6

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

740

1.22

1.05

1.4

1.5

29.5

30.1

0.05

454

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

418

1.29

1.05

1.1

1.2

1.1

ratio

0.00

140

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

271

2429

1.12

1.05

1.5

1.3

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

245

1.39

1.05

1.4

1.3

52.5

54.6

0.11

208

(4306422)

126

1071

1.18

1.04

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

237

1.39

1.04

3.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.27

1.03

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.96

1.03

1.3

1.2

—

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

634

1.23

1.02

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

204

1.42

1.02

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

204

1.42

1.02

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

204

1.42

1.02

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

204

1.42

1.02

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

197

1.42

0.99

1.3

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

231

1.39

0.99

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

865

1.19

0.99

2.3

3.6

62.4

58.4

1.18

544

(37021550) Renin [Units/volume] in Plasma --upright

181

1.44

0.98

1.1

1.3

105.9

68.6

mu/l

0.32

132

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

309

1.33

0.98

1.1

—

(40762814) Titanium [Mass/volume] in Blood

148

1.49

0.97

2.0

2.2

3.8

4.1

ug/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.95

0.97

1.0

1.1

9.4

8.4

mmol/l

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

1.95

0.97

1.0

0.0

4.1

u/ml

—

(3003740) Influenza virus B Ag [Presence] in Specimen

116

988

1.18

0.95

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

175

1539

1.14

0.95

5.5

5.1

1628.4

2237.1

iu/ml

0.16

213

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

126

1082

1.17

0.94

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.61

0.93

1.0

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.22

0.93

1.0

1.1

—

26.9

—

(3005011) Chlamydia sp Ab [Titer] in Serum

109

1.56

0.93

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

217

1.38

0.93

1.1

1.2

—

(44806420)

257

0.66

0.92

2.2

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

899

1.18

0.92

1.5

1.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.72

0.92

1.1

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.14

0.91

1.7

1.5

21.4

14.2

nmol/l

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

103

0.49

0.89

7.6

5.9

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

103

0.49

0.89

3.8

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

126

1452

0.87

1.3

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

307

1.30

0.86

2.8

2.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

667

1.20

0.86

2.1

2.4

2.0

u/field

0.26

252

(3045716) Anion gap in Serum or Plasma

387

1.27

0.86

1.3

2.1

8.6

9.4

mmol/l

0.82

303

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

195

1.39

0.85

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

652

1.20

0.82

1.5

—

(3017704) Immunofixation for Urine

462

1.24

0.81

1.2

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

114

986

1.16

0.81

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

264

2405

1.10

0.81

1.9

1.7

—

(40768793) Breast Pathology biopsy report

168

1886

0.89

0.80

1.3

—

(3017569) Oxygen content in Arterial blood

418

1.25

0.80

2.4

2.1

—

(40768446) Kidney Pathology biopsy report

285

1.30

0.79

1.8

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

294

0.71

0.79

1.4

1.5

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.79

0.0

4.4

—

4.8

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

305

0.72

0.79

1.7

1.6

—

(3003694) ABO and Rh group [Type] in Blood

2153

20939

1.04

0.78

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

429

1.24

0.77

2.1

1.9

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.77

0.0

1.1

—

(4015189)

234

1.33

0.77

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

115

1.48

0.76

10.6

12.5

7.2

5.3

mmol/l

0.64

115

(3000285) Sodium [Moles/volume] in Blood

115

1.48

0.76

1.0

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

157

1.40

0.76

1.6

2.3

1.2

mmol/l

0.50

151

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.64

0.75

1.1

—

(3025130) Human papilloma virus identified in Specimen

105

910

1.16

0.75

1.8

1.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

201

1.34

0.74

2.4

5.9

66.7

71.4

0.32

156

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.80

0.72

1.3

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.55

0.71

4.8

3.6

8.1

7.3

mmol/l

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

822

1.16

0.70

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

508

1.20

0.70

1.8

1.5

52.5

69.4

umol/l

—

(3002619) Bacteria identified in Specimen by Culture

160

1.38

0.70

1.5

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.71

0.70

24.1

13.3

448.1

236.5

e6/l

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

620

1.18

0.68

1.1

1.2

—

(3048879) Bone marrow aspiration report

248

1.29

0.68

1.3

1.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.53

0.68

2.9

2.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

465

1.21

0.67

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

330

1.24

0.66

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

412

1.21

0.65

4.3

4.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

198

1.31

0.63

1.7

1.9

8.8

9.3

mg/l

0.21

161

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

450

1.20

0.63

1.6

1.5

—

(3014891) Appearance of Pleural fluid

112

1.43

0.63

1.1

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

988

0.87

0.63

1.3

7.3

7.5

mmol/l

0.25

718

(3001964) Herpes simplex virus Ag [Presence] in Specimen

235

0.72

0.63

1.6

1.4

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

1.44

0.62

1.0

1.2

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

1.60

0.61

1.0

1.1

—

4.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

155

1401

1.11

0.61

2.5

3.5

1.1

1.5

0.76

127

1064

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

448

4230

1.06

0.61

2.6

3.7

51.5

71.1

u/ml

0.65

420

4068

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

227

2091

1.09

0.60

3.7

3.3

1.6

mg/l

0.03

209

1907

(3019897) Erythrocyte distribution width [Ratio] by Automated count

824

0.86

0.60

3.2

3.0

13.2

0.22

816

(21494814) CD8 cells/100 lymphocytes in Specimen

316

1.24

0.60

2.1

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.59

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

236

1.27

0.59

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

463

1.19

0.59

1.1

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

790

0.86

0.59

1.3

1.5

—

(40768806) Pleura Pathology biopsy report

918

0.87

0.59

1.6

—

(44806071)

1.46

0.57

1.2

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.71

0.57

1.2

1.3

8.0

1.2

u/ml

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.71

0.57

1.2

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

149

1.34

0.57

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

447

1.19

0.57

1.1

1.2

—

(3024263) Appearance of Synovial fluid

429

1.19

0.56

1.7

1.6

—

(3045142) Bone marrow Pathology biopsy report

935

0.88

0.56

1.2

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.58

0.56

1.6

2.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.54

0.55

1.0

0.6

0.2

u/ml

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

206

0.73

0.55

1.3

1.6

12.3

13.5

g/l

—

163

(21494815) CD4 cells/100 lymphocytes in Specimen

616

1.15

0.55

2.5

2.2

45.8

41.6

0.36

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

449

1.18

0.54

1.6

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

208

1922

1.08

0.54

1.3

269.9

222.7

miu/ml

0.98

861

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

267

1.24

0.53

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

147

0.68

0.53

3.8

6.6

—

(3042631) Mycobacterium sp identified in Specimen

129

1166

1.11

0.53

2.7

2.8

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

621

0.85

0.53

1.3

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

497

1.17

0.53

1.6

1.8

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.54

0.53

1.5

1.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.43

0.52

1.2

1.7

—

(3019174) dRVVT (LA screen)

1.43

0.52

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

117

1.37

0.52

1.4

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

117

1.37

0.52

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

117

1.37

0.52

1.4

1.2

—

(3036603) Volume of Urine

554

1.16

0.52

1.4

1.6

1664.6

1916.1

0.62

143

(3046861) Legionella sp Ag [Presence] in Urine

1.50

0.51

1.5

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.50

0.51

1.5

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.50

0.51

1.0

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.41

0.51

1.0

1.1

—

3.7

—

(3025315) Body weight

1.38

0.50

5.7

4.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.49

0.49

1.1

—

(3042733) HLA Ab [Presence] in Serum

216

1.25

0.49

5.4

4.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.43

0.49

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

154

1.30

0.48

1.7

3.3

141.5

152.4

ng/l

—

(3000330) Specific gravity of Urine by Test strip

407

4280

0.95

0.48

3.6

—

(3009871) Measles virus Ab [Titer] in Serum

222

0.77

0.47

1.6

1.7

—

(3020393) Adenovirus Ag [Presence] in Stool

1.41

0.46

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

514

1.15

0.46

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

384

1.17

0.45

1.2

—

(40758292) HTLV I+II Ab panel - Serum

121

0.66

0.45

1.1

1.4

—

(3022689) Creatine [Moles/volume] in Urine

230

0.78

0.43

1.4

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.61

0.43

1.0

1.1

557.2

266.4

nmol/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.40

0.42

1.4

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

258

1.20

0.41

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

417

1.15

0.40

1.3

5.7

5.9

mmol/l

1.11

398

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

177

1.24

0.40

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

107

1170

0.91

0.40

1.7

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

153

1420

1.08

0.40

1.4

1.5

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.39

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.32

0.37

2.7

5.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

188

1.22

0.37

1.9

2.3

8.4

7.8

mmol/l

0.19

118

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

328

1.16

0.36

1.9

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

328

1.16

0.36

1.9

2.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

245

1.18

0.35

1.2

1.3

73.0

377.3

ug/l

1.23

127

(3022475) Manganese [Moles/volume] in Blood

1.36

0.34

1.0

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.33

0.33

1.0

—

(40765096) Chromosome analysis panel by Banding

232

0.82

0.33

1.4

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.30

0.33

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

791

1.09

0.30

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

791

1.09

0.30

1.2

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

193

1.19

0.30

3.4

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.30

0.30

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

174

0.80

0.29

1.1

1.9

2.0

2.1

ug/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.25

0.29

1.9

2.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

130

0.77

0.29

1.9

2.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

941

0.92

0.29

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

260

1.15

0.28

2.0

27851.5

18916.2

e6/l

0.17

142

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

184

0.81

0.28

3.3

2.4

—

(3016750) Collection duration of Urine

459

1.11

0.28

2.3

2.1

490.7

498.0

min

0.21

328

(3010375) cycloSPORINE [Mass/volume] in Blood

345

1.13

0.28

34.4

25.4

107.6

108.2

ug/l

0.03

283

(40768795) Lymph node Pathology biopsy report

815

0.92

0.28

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

921

9022

1.02

0.27

3.3

4.1

15.4

28.6

ug/l

1.18

736

7356

(3013727) Leukocytes other/100 leukocytes in Blood

281

1.14

0.26

3.3

3.5

54.3

54.6

0.03

268

(3037556) Urate [Mass/volume] in Serum or Plasma

257

0.86

0.26

1.5

1.4

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.28

0.26

1.0

1.2

156.3

110.5

ug/l

—

(3000012) Reticulocyte production index

473

1.10

0.25

1.2

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

170

1.18

0.24

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

331

1.12

0.24

2.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.32

0.23

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

418

1.10

0.23

2.3

2.1

122.5

166.7

ug/min

0.17

101

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

209

1.15

0.22

1.4

1.3

35.0

35.3

0.01

139

(3002331) Protein [Mass/volume] in Peritoneal fluid

181

1.16

0.22

2.0

1.3

32.0

27.3

g/l

0.62

143

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.25

0.22

1.4

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.25

0.22

7.2

3.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

493

0.91

0.22

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.19

0.21

1.2

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1466.4

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

126

1.19

0.21

1.4

1.6

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.24

0.20

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.24

0.20

1.0

—

(3036670) Protein [Mass/volume] in Synovial fluid

272

0.88

0.20

1.3

1.2

39.3

39.5

g/l

—

140

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

192

1.15

0.20

1.5

1.2

—

(3018133) Calcium [Moles/volume] in Urine

117

1.20

0.20

2.8

1.7

2.7

2.5

mmol/l

0.17

102

(3041184) Isoniazid [Presence] in Urine

0.00

0.20

0.0

2.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

693

1.07

0.20

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.21

0.19

1.3

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.15

0.19

2.8

3.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

270

1.11

0.18

1.7

1.9

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

725

1.06

0.18

2.1

2.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

252

1.11

0.17

1.7

1.8

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

195

0.87

0.17

4.2

7.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

610

1.07

0.17

1.3

13.7

13.0

u/l

0.15

558

(3001729) Color of Synovial fluid

1.18

0.16

1.1

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

101

1.19

0.16

1.3

1.2

—

112.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

107

1024

1.05

0.15

1.4

1.5

3912.1

1843.6

e6/l

0.90

734

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

168

1.13

0.15

1.0

—

(40768800) Prostate Pathology biopsy report

151

1565

0.96

0.15

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.77

0.15

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.13

0.15

1.1

1.2

—

(3024471) HLA-A [Type]

223

0.90

0.14

1.1

1.0

—

(4211845)

440

0.93

0.14

4.0

3.4

—

(3047189) Immunofixation for 24 hour Urine

401

1.07

0.14

1.7

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

256

1.09

0.14

2.5

1.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

931

1.04

0.13

1.4

1.5

80072.9

70089.1

e6/l

0.09

547

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

185

1800

1.03

0.13

1.3

1.4

90.5

173.6

pmol/l

5.14

179

1754

(3038071) Oxygen [Partial pressure] in Mixed venous blood

169

0.89

0.12

3.7

7.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

291

0.93

0.11

2.2

432.2

5103.4

e6/l

0.86

202

(3003434) Protein [Mass/volume] in Pleural fluid

113

1166

0.97

0.10

1.4

1.5

32.4

32.2

g/l

0.05

102

1046

(3034426) Prothrombin time (PT)

260

1.08

0.10

1.1

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

299

3043

0.98

0.10

2.8

3.4

677.1

2369.6

u/ml

0.98

246

2603

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.14

0.10

1.4

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

203

1.08

0.09

1.1

—

(3004775) Volume in Urine collected for unspecified duration

656

0.96

0.09

2.4

2.2

576.4

650.2

0.91

425

(4212803)

1.15

0.09

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.04

0.09

3.8

3.1

—

0.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

497

1.05

0.09

6.4

6.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

165

1.09

0.08

1.1

1.3

—

(3035880) pH of Pleural fluid

471

0.96

0.08

1.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.03

0.08

1.2

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

154

0.91

0.08

1.6

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

174

0.92

0.07

1.3

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.08

0.07

1.0

—

(40768441) Liver Pathology biopsy report

591

0.96

0.07

1.4

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.07

0.07

1.7

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

782

0.97

0.07

2.7

3.0

17.6

50.4

mg/l

2.13

574

(3051387) C reactive protein [Mass/volume] in Capillary blood

174

1770

0.98

0.07

5.8

3.5

24.5

27.7

mg/l

0.55

105

1121

(3042010) Triglyceride [Moles/volume] in Pleural fluid

128

1.09

0.06

1.2

1.5

1.8

mmol/l

—

(40757373) Influenza virus identified in Isolate

152

0.92

0.06

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

553

1.03

0.05

2.0

1.9

3.6

ug/l

0.02

485

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

129

1.09

0.05

1.1

58.2

54.3

u/ml

0.07

123

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

129

1.09

0.05

1.1

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

644

1.03

0.05

1.3

1.4

2.9

3.8

ug/l

0.80

548

(3013293) Extractable nuclear Ab [Presence] in Serum

120

1.08

0.04

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

201

2032

0.99

0.04

1.3

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

109

0.92

0.04

1.0

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

119

0.92

0.03

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

129

0.93

0.03

4.1

7.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

279

0.97

0.02

1.6

1.4

—

(3025577) Chromium [Mass/volume] in Blood

540

1.02

0.02

2.0

2.2

2.5

ug/l

0.29

452

(3012441) Differential panel - Pleural fluid

899

1.01

0.02

1.4

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

1780

1.01

0.01

2.4

3.4

535.1

689.9

u/ml

0.18

168

1621

(3024932) HLA-DR beta [Type]

217

0.97

0.01

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

217

0.97

0.01

1.1

1.7

—

(21494434) Karyotype in Bone marrow

722

1.01

0.01

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

363

1.02

0.01

1.6

1.5

7.8

8.1

mmol/l

0.24

220

(3006462) Nitrate [Presence] in Urine

403

1.02

0.01

4.0

3.5

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

114

1.05

0.00

1.4

1.2

29.4

328.0

u/l

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

214

1.03

0.00

2.1

1.5

9.0

8.7

ug/l

0.13

214

(3033799) Differential panel - Peritoneal fluid

266

0.98

0.00

2.8

1.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

784

1.01

0.00

1.3

1.4

5.8

6.4

mmol/l

1.07

723

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.05

0.00

2.2

1.9

—

(4133840)

192

0.99

0.00

1.3

1.2

—

(3044007) Cell count panel - Peritoneal fluid

238

1.01

0.00

3.0

1.9

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

418

1.00

0.00

2.8

2.6

38.9

38.4

0.05

152

(40765089) Chromosome analysis panel - Blood by G-banded

141

0.99

0.00

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

109

1.01

0.00

6.2

10.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

571

1.00

0.00

1.6

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

661

1.00

0.00

1.6

1.8

3.9

4.2

mg/l

0.22

629

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

2.3

—

4.8

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

88.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.92

0.00

5.0

2.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.91

0.00

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.02

0.00

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.91

0.00

1.3

1.2

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

0.00

0.0

1.1

—

71.6

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.01

0.00

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.97

0.00

1.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

173.3

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.93

0.00

1.8

1.2

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_XTRAPYROTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.297 [1.18, 1.42]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.201

During the follow-up period (1.1.1998 — 31.12.2019), 5348 out of 24658 females with G6_XTRAPYROTH died.

Males

Parameter	HR [95% CI]	p-value
G6_XTRAPYROTH	1.541 [1.4, 1.7]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.023

During the follow-up period (1.1.1998 — 31.12.2019), 5694 out of 19166 males with G6_XTRAPYROTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_XTRAPYROTH.

N-year risk	Females	Males
1	0.113%	0.318%
5	0.748%	1.726%
10	1.92%	4.587%
15	3.477%	8.658%
20	6.49%	14.437%

Relationships between endpoints

↥

Index endpoint: G6_XTRAPYROTH – Other extrapyramidal and movement disorders in other diseases

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other extrapyramidal and movement disorders in other diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints